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ABSTRACT
The dimensions of microfluidic devices closely parallel those of biological cells;
thusly, they are excellent platforms for the speciation, transport, manipulation, and
analysis of cells. Electrokinetic transport of Escherichia coli and Saccharomyces
cerevisiae was evaluated in microfluidic devices fabricated in pristine and UV-modified
poly(methylmethacrylate) and polycarbonate. The magnitude and direction of transport
of the cells was dictated by the buffer composition, conduit surface chemistry, and
intrinsic cellular electrical properties. Baker’s yeast in all devices migrated toward the
cathode, because of their smaller electrophoretic mobility compared to the
electroosmotic flow of the polymer. E. coli cells suspended in 20 mM PBS migrated
toward the anode, which indicated that the apparent mobility of the E. coli cells changed
direction at higher ionic strengths. The observed differential migrations were exploited to
sort cells, whereby judicious choice of the buffer concentration and the polymeric
material in which the cell sorting was performed was controlled, allowed for cell
enumeration via laser-based backscatter signals.
A novel microfluidic device that selectively and specifically isolated the exceedingly
small numbers of circulating tumor cells (CTCs) from whole blood through a monoclonal
antibody (mAB) mediated process by sampling large input volumes (≥1 mL) of whole
blood directly in short time periods (<37 min) was designed, manufactured and
implemented. Upon processing, the CTCs were concentrated into small volumes (190
nL) and the number of cells captured were read without the need for labeling by using
an integrated conductivity sensor following an enzyme mediated release of the captured
CTCs from the microchannel surface. The microchannel walls were covalently
decorated with mABs directed toward breast cancer cells that over-express epithelial
xvii

cell adhesion molecules. The released CTCs were then enumerated on-device using
conductivity detection with 100% detection efficiency and exquisite specificity for CTCs.
The CTC capture efficiency was made highly quantitative (>97%) by designing capture
channels with the appropriate widths and heights. Extension of the technique to
environmental samples was performed using analogously patterned polyclonal anti-E.
coli O157:H7 antibodies directed towards the virolent bacterial strain were used to
isolate the enterohemorrhagic bacteria while E. coli K12 were not adsorbed to the
antibody containing surface.
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Introduction
I.1 Origins of Life
The biological cell is the most fundamental of organisms that embody life processes.
Individually these small wonders can be considered the manufacturing facilities from
which all biological processes find their origins.1 On a grandiose scale the full gambit of
all known biological cells can be classified as one of two major classes: (i) prokaryotic or
(ii) eukaryotic. The root, Karyotic refers to the nucleus or control center of the cell. The
nucleus is enclosed by a sub-membrane within the primary cellular envelope yet
separated from it by the cytoplasm. “Eu”, from the Greek, means true and from this one
can surmise that the eukaryotic cell possesses a nucleus and conversely the
prokaryotic cell does not.
I.2 Cell Biology: Prokaryotes and Eukaryotes
In this dissertation, I focus on cells originating from the Monera and Anamalia
Kingdoms, primarily owing to the clinical, environmental, and medical information that
can be ascertained from the cellular contents. Clinicians are actively pursuing means of
isolating, quantitating, and subsequently examining these cells due in part to toxic,
virulent,

and

pathogenic

potentials

possessed

by

the

various

cell

types.2-4

Morphologically, prokaryotes are smaller and less complicated cells typically 5 μm in
diameter or smaller with an outer membrane that is composed of a phospholipid bilayer
that encompasses a cytoplasm and nucleoid rather than a nucleus.5,6 In this cell type
there exists a high probability of finding genetic materials in the nucleoid.6 It is widely
held in the scientific community that the initial prokaryotes through a series of symbiotic
processes took up residence within the early eukaryotic cells significantly increasing
their

complexity

during

the

evolutionary
1

cycle.6,7

Specifically,

plastids8

and

mitochondria9 are cited as originating as free-living prokaryotes that found shelter within
primitive eukaryotic cells.6 As evidenced by the present form of eukaryotes, these
moieties eventually became stabilized as permanent symbiotic elements within
eukaryotes cellular envelope making eukaryotes larger and more complicated than their
counterparts.7

5’

3’

Figure I.1 Illustration of the DNA forming a double helical structure with an expansion of
the sugar phosphate backbone. Adapted with permission from www.cnx.org 7/11/2008.
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I.3 Molecular Biology
I.3.1 Nucleic Acids. A molecule of deoxyribonucleic acid is composed of a series of
smaller subunits. DNA primarily consists of two polymer chains of deoxyribonucleotides
that are bound by a hydrogen bonding between each pair of complementary bases.
Each nucleotide base exists as a separate unit having its own deoxyribose residue and
a phosphate group. Figure I.1 illustrates the deoxyribose sugar unit and the four
nucleosides. The four nucleic acids (nucleosides) are grouped into two classes of
molecules, pyrimidines and purines. Adenine and guanine are purines that have an
imidazole ring fused to the pyrimidine ring. Cytosine and thymine are pyrimidines having
a basic six member ring structure with two nitrogens at the 1 and 3 positions.1
The nucleosides along with a deoxyribose sugar unit through a Β-N-glycoside bond
between the first carbon C1 of the sugar unit and either the first nitrogen group N1 of the
pyrimidines or the N9 group of purines in conjunction with the hydroxyl group at the C5
(5’-carbon) position can be converted to a phosphate ester, at which point the three
units together form a deoxyribonucleotide (nucleotides). Analogous units then link to
form a polymer chain via phosphodiester linkages between the C5 phosphate ester and
the C3 group (3’- carbon) of the next deoxyribonucleotide unit. In this manner, the
molecule forms through a backbone or a continuous linkage of C5 – C3 (5’ → 3’)
phosphodiester linkages. The end of the linear polymer having no nucleotide linked to
the 5’-carbon is said to be the 5’-end while the opposite end, which has no residue at
the 3’-carbon, is said to be the 3’-end. This labeling lends itself to some directionality in
reading the chain from one terminus to the other, with the forward direction always
denoted as 5’→3’.1
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DNA acquires its double helical shape from the bonding of the nucleotide bases from
one chain with those of the other. In a molecule of DNA, the two linear polynucleotide
chains are oriented anti-parallel to each other as demonstrated in Figure I.1, with one
chain oriented in the 5’→3’ direction, and the anti-parallel chain in the 3’→5’ (reverse
direction). The ordering of the nucleotide bases from the 5’-chain is complementary to
the order of the bases in the 3’-chain. If a planar structure of the molecule is imagined, it
would be similar to a ladder, with the nucleotide bases forming the steps, and the sugarphosphate backbone holding the steps together. The helical formation is partly the
result of the simple hydrogen bonding between the nucleotide bases. Based on their
structures and the specific binding affinity of each, it is noticed that guanine and
cytosine are bound through three hydrogen bonds, while adenine and thymine are
bonded through two hydrogen bonds; the double helix is achieved specifically from this
purine:pyrimidine pairing. Other pairing possibilities are strictly forbidden. Guaninethymine and adenine-cytosine bonds would result in mismatches because the pattern of
hydrogen acceptors and donors do not correspond. The close proximity of guanineadenine (purine) molecules bound together is energetically unfavorable, while thyminecytosine (pyrimidine) bonds are energetically unfavorable since the molecules would be
too far apart for hydrogen bonding.1
I.3.2 Genetic Link to Tumor Development. Within the DNA are regions (~1%)
responsible for coding proteins.10 Some genes can be correlated to physical traits such
as eye or hair color while other genes with specific combinations of errors are correlated
with proliferative unregulated cell growth that can result in the development of a genetic
disorder termed cancer. In particular, this type of gene is referred to as an oncogene.
During early developmental stages of a neoplasm cells with an inherent resistance to
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apoptosis, programmed cell death, have the potential to multiply at alarming rates.
These cells typically have many cell adhesion molecules decorating their periphery and
as a result these cells tend to aggregate forming the tissue that is ultimately referred to
as a tumor. In order for tumorigenesis to occur tumors require vascularization to thrive,
because oxygen and other blood borne necessities such as divalent cations are
necessary components for tumor survival.
I.4 Circulating Tumor Cells
Circulating tumor cells (CTCs) occur with exceedingly low frequency within the
peripheral blood matrix, as a result these cells are rare comprising as few as one cell
per 109 haematologic cells in the blood of a patient with metastatic disease; thereby,
indicating the tremendous technical challenges of attempts to isolate and enumerate
CTCs. Microfluidic cell handling devices provide seemingly ideal platforms for speciating
these events and moderate successes have been yielded in microfluidic flow
cytometry,11,12 continuous size based separation,13-15 and even chromatographic
separations.16 The essential parameters that determine efficiency of cell capture on a
microfluidic platform are: 1) flow velocity, because it dictates residence times;17 2)
throughput, because rare events require processing large samples;18 and 3) collision
probability, because the cells must interact with the walls in order for a binding event to
occur.18
CTCs originate from primary neoplastic sites and are subsequently disseminated
into the circulatory system and transported by the peripheral blood through a
multivariate process termed the “metastatic cascade”. The metastatic cascade is
referred to as a series of well defined interdependent events leading to a clinically
relevant overt lesion.19 The single most relevant prognostic factor in epithelial derived
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tumors is the metastatic infiltration of distant organs. For example, in International Union
against Cancer (UICC) stage II colon cancer patients with locally limited tumor
progression have survival rates of 75% contrasted with only 13% for UICC stage IV
patients who have evidenced distant organ metastasis.20 In an analogous manner, in
the much more heterogeneous breast cancer diseases the metastatic spread has the
most important impact on the patient’s outcome.21 Further, metastatic evidence in the
blood and/or bone marrow is also indicative of prognostic impact.22 Triggering the
cascade is a process called the epithelial-mesenchymal transition (EMT). This
phenomenon enables otherwise stationary epithelial cells to migrate causing invasion
into surrounding tissues eventually resulting in the detachment of neighboring cells and
release into in the microenvironment. The scheme for this process is not completely
understood; however, several integral components have been identified such as the
receptor tyrosine kinase, growth factors, GTPases, and integrins that are closely
associated with cell adhesion and migration.23-25
I.4.1 Natural Defense from Proliferation Metastasis. The process of hematogenous
transport of the disseminated cells is an inherently destructive process that’s considered
the first line of defense against metastatic disease.26 From the onset of tumorigenesis
CTCs can be released from the very small micrometer scale tumors. Upon being shed,
the CTCs are fragile and lack interactions with blood borne fibrin and platelets, and as a
result the membrane can be easily destroyed by sheer stress imparted by blood flow.26
In addition, natural killer cells termed Pit cells27 and Kupffer cells28 attack the neoplastic
cells immediately upon release.29 Presence of the CTC in the peripheral blood triggers
as much as an 80% increase in the number of natural killer cells within the peripheral
blood in a matter of minutes. Most tumor cells subject to hematogenous transport are
6

either mechanically destroyed from the sheer stress of blood flow rupturing the cells
membrane or the CTC undergoes a process called anoikis, a special form of cell death
resulting from an adhesion deficiency. The vast majority of the carcinoma cells are killed
within a few hours of dissemination through the natural defense systems, thereby
demonstrating the relatively low efficiency of metastatic events.30
I.4.2 Metastatic Tumor Progression. Cancers that originate in organs such as the
mammary glands, colon, and/or prostate are forms of adenocarcinomas. Most often,
tumors develop in the organs proximal to capillary beds, owing in part to the metastatic
CTC surviving the natural protections provided by the circulatory system. This survival is
further supported by the CTC developing a protective barrier consisting of fibrin and
platelets sufficient to prevent lysis from blood flow related sheer stress by providing
stabilizing reinforcement, and barrier like protective coating from natural killer cells.
Subsequently, the surviving CTCs are arrested in capillary beds in which adhesion
molecules of the distant organ act on receptors in the CTC membrane forming
complexes. Aiding this process is the relatively narrow bore of the capillaries resulting in
increasing the probability of adhesion, based on the CTCs and receptors being
proximally within binding range of the adhesive molecules on the surface for extended
periods due to decreased mobility. Subsequently, extravasation results when the tumor
cells migrate across the capillary wall. The morphology of cancer cells is distinct, these
cells are often larger (15 – 40 μm dia.) than normal haematopoetic cells and they harbor
above average sized nuclei.31
I.5 Human Concerns
Cumulatively, cancer is the leading cause of death among the world population and
the causes of cancer are generally considered to be some combination of
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environmental, occupational, and/or hereditary factors.32 Though no point source can be
cited in most cancer cases, all cancers stem from specific sets of combinations of
defects in the genetic code.1,26 In many cases even this is obscure and not well
understood. These defects can be caused by insertion, deletion, or substitution of bases
in the genes resulting in producing proteins that have markedly different behaviors.1,26
As a result, CTCs are of interest to researchers, because they can provide insight into
disease states, and when quantified they can provide both valuable prognostic and
diagnostic information about patients.33
I.6 Environmental Concerns
Some prokaryotes, though indigenous to humans and animals that humans
consume can be toxic and potentially lethal.34 The number of cells required for such an
outcome varies, but is contingent upon the nature of cell at issue. As an example as few
as 10 Escherichia coli 0157:H7, an enterohemorrhagic bacterium, can proliferate in the
digestive system causing Shigella dysentery, a potentially fatal disease if not
treated.35,36 Conversely, a benign strain (K12) of bacteria of similar origin that of the
0157:H7 variety is harmless.37 Morphologically these two strains are identical, but they
express markedly different proteins due to differences in their DNA. The toxic strain
produces shiga-like toxins referred to as SLT-I and SLT-II.38 These bacteria are
indigenous to the gut of bovine animals, and can be isolated from pastures containing
feces from the animals. Through precipitation and subsequent runoff these dangerous
cells work their way into the water table impacting ground water and aquifers.39
Maintaining safe recreational areas, fisheries, and drinking water is contingent upon
being able to readily identify and quantitate the contaminants on site.
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I.7 Research Focus: Need for Greater Selectivity, Sensitivity, and Portability
In this dissertation, I investigate the use of surface modification chemistries and
electrokinetic pumping in polymer-based microfluidic devices as a means of controlling
the rate and direction of movement of cells in suspension. I also present data from the
hydrodynamic manipulation of cells in analogous devices. The need for sensitive
selective methods to isolate, enumerate, and phenotype low abundant biological cells is
apparent whether the need arises as a result of United States of America Environmental
Protection Agency USEPA mandates on water quality or if the need is in the clinical
setting at the point of care there exists a need for rapid approaches to selectively
speciate and evaluate particular cells from often complex matrices i.e. peripheral blood.
Nagrath et al. recently presented a device capable of selecting rare cancer cells, but to
date, no methodologies presented completely satisfies clinical need.17 I present a novel
approaches toward real solutions to these problems.
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Chapter 1 Recent Microfluidic Approaches toward Cellular Analyses: A Literature
Review
1.1 Introduction
Biological cells have been of interest to researchers performing bioassays since the
imaging of the first cell by Anton von Leeuwenhoek in 1674.1 About two centuries later,
Ashworth observed an atypical cell type in the peripheral blood that morphologically
appeared to be of epithelial origin and was designated as a tumor cell.2 Since then,
isolating and enumerating circulating tumor cells based on phenotype has been of
interest in many basic, clinical, and medical research settings. The challenge with using
circulating tumor cells present in peripheral blood, or other clinical samples, as a cancer
diagnostic marker is the extremely low frequency in which these cells appear in relative
to other cell types. For example, it is not uncommon to find 5 – 10 tumor cells in 1 mL of
whole blood that also contains 107 red blood cells (erythrocytes, RBCs) and 103 white
blood cells (leukocytes, WBCs). Therefore, enrichment factors exceeding 107 must be
obtainable by the equipment used to select and subsequently enumerate these cells.
Unfortunately, cancer cells will proliferate due to the cells’ lack of appropriate cues
for apoptotic or programmed cell death resulting from a combination of genetic defects,
which inevitably provides their ability to survive circulation and adhere to secondary
sites giving rise to metastatic disease.3 As a matter of definition, neoplastic cells
originating from a primary site are often referred to as tumor cells.4 The term “tumor cell”
can be applied to both benign and malignant varieties of neoplastic cells; however, only
malignant cells are aptly termed “cancer cells”. As such, circulating tumor cells (CTCs)
can or will not spawn metastatic disease depending upon their genetic makeup.
Morphologically, tumor cells are typically smaller than normal epithelial cells and
they possess larger nuclei with small cytoplasmic regions (see Figure 1.1). These
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morphological differences make them easy to differentiate with respect to normal
epithelial cells, which typically do not appear in peripheral blood.5 The characteristic
features of cancer cells’ morphology has been linked in part to the pentose phosphate
pathway (PPP) generating an increase in glucose metabolism of cancer cells during
proliferation.3

A

B

Figure 1.1 Micrographs of (A) normal epithelial cells and (B) malignant epithelial tumor
cells. Note the larger size of the normal epithelial cells compared to the tumor cells.
Reprinted with permission.6

Besides morphological differences, the molecular composition of tumor or cancer
cells substantially differs from that of normal epithelial cells as well. Many cancers are
characterized by mutations within the genome of tumor/cancer cells that can give rise to
gene silencing or gene hyperactivity resulting in the over-expression of various
molecular entities, such as integral membrane proteins. For example, many
adenomacarinomas over-express the epithelial cell adhesion molecule (EpCAM),7 or in
the case of prostate cancer, the prostate specific membrane antigen (PSMA).8
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Metastasized epithelial cells undergoing hematogenous transport are atypical in
healthy human blood.9 However, many adenocarcinomas are characterized by tumor
cells shed from the primary tumor site into the peripheral blood. As noted above, the
number of these cells in the peripheral blood is extremely low compared to the RBC and
WBC count. For example, the number of tumor cells from breast cancer patients can be
in the range of 5 per mL of whole blood.10
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Figure 1.2 Processing time as a function of the fluidic cross-section using microfluidics
at three different linear velocities. The total volume sampled is 1.0 mL. Note the 35 ×
150 μm2 cross-section indicated in the figure for a single or 51 parallel channels. These
dimensions were used in the device described in Chapter 3 of this dissertation.
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The predominate techniques used to select rare tumor cells from peripheral blood or
other biological/clinical samples has been carried out using fluorescence assisted cell
sorting (FACS) or magnetic assisted cell sorting (MACS);11,12 the complexity of
FACS/MACS instrumentation and the required operator expertise makes these
techniques prohibitive toward their widespread adoption for screening applications,
which has facilitated a strong interest in producing simpler and more efficient methods
for sorting and the subsequent enumeration of these rare cells.13
For sampling rare events, four important metrics must be assessed: i) throughput,
the number of cell identification or sorting steps per unit time; ii) recovery, an indicator of
the fraction of target cells collected from the input sample; iii) purity, which depends on
the number of “interfering” cells excluded from the analysis; and iv) analysis time, which
is the time it takes to process a specified volume of sample exhaustively.14 In addition
to these metrics, highly efficient quantification of the number of enriched cells must be
provided as well.
Throughput is directly proportional to the cross-sectional area of the conduit through
which the sample is delivered and the sample volume required for interrogation (see
Figure 1.2). The input sample volume required for the assay is determined by the
frequency of cell appearance in the sample. At 5 cells mL-1, a sampling volume of 1 µL
would produce a probability of finding the cell in that volume of only 0.5%. Because
CTCs are of low frequency (1 – 10 cells mL-1), high volume sampling (≥1 mL) is required
to increase the probability of isolating these rare events. If the cross-sectional
dimensions of 35 x 35 µm are employed to exhaustively search for rare cellular events
when the transport rate is 10 mm s-1, and an input volume of 1.0 mL is required, the
sampling time would be approximately 278 h. For cell sorters consisting of a single
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rectangular via with dimensions of 150 × 35 µm under similar conditions the sampling
time would reduced to approximately 5.6 h. However, if the 150 × 35 µm conduit were
highly parallelized by incorporating 51 vias, the processing time drops to 0.12 h as
shown in Figure 1.2. The time it takes to process 1.0 mL of fluid at varying linear
velocities for channels with different cross sectional areas are also shown in Figure 1.2.
As can be seen, increases in the linear transport rate does affect the processing time,
with higher transport rates reducing the processing time.
The purity of the enriched targets is also critical, because impurities can result in the
generation of false positives. For molecular recognition used for cell selection, the level
of purity is predicated on the specificity of the recognition element used for its binding
partner. For size-based selection, cells with sizes similar to the target cells can provide
potential interferences. For example, recovery rates using size selection can typically
be on the order of 60%, but are often marred by interferences resulting in low purity
enrichments caused by contaminating leukocytes due to the similarity in sizes of the
WBCs and tumor cells.15-19 Attempts to further pre-concentrate the targets and remove
potential WBC interferences introduce a significant risk of target loss.15,20
There exist two extremes pertaining to the habitat of the target cell. One extreme is
that of a relatively simple sample matrix containing few cell-like constituents that would
potentially interfere. At the other extreme is whole blood; 40 – 57 (w/w)% of normal
peripheral blood from a healthy person consists of suspended solids in the form of
leukocytes and erythrocytes.21 For this reason, analyzing blood directly has presented
several distinct challenges requiring in most cases, various types of sample
pretreatment prior to the cell sorting. These pre-treatments range from serial dilution (up
to 10-fold)22 to density gradient centrifugation,23 whereby particles with distinct mass-to17

volume ratios are separated into layers of varying density [40 – 70%(w/w)] in a
cushioning medium via centrifugal force.24 Initially, layers of varying concentrations of
sucrose are added to a vessel with the least dense layer being added first with
subsequent layers with increasing densities being added above the seed layer. The last
layer added to the vessel contains the sample suspension with the target cells.
Depending on particle density, a centrifugal force of as much as 150,000×g is applied to
the sample using ultracentrifugation resulting in all constituents originating in the sample
residing in the layer of solution that matches the density of the respective particles.
Layers containing the targets are harvested by recovery with a pipette. These
techniques typically provide 70 – 90% target cell recovery.25 In terms of whole blood,
density gradient centrifugation is used to remove the RBC fraction of whole blood,
leaving only the mononucleated fraction for cell selection of the targets.
There are fundamentally two different device formats that can be used for selecting
rare cells from mixed populations, macro-scale systems and micro-scale systems.
Macro-scale systems are attractive for selecting rare cells due to their ability to process
large input volumes easily while conventional microsystems do not possess the ability to
process large input volumes as easily (see Figure 1.1), which is required to generate a
high statistical confidence for successfully securing the rare cells from the processed
sample.
1.2 Transport Phenomena
Blood is a uniquely complex fluid composed of deformable cells suspended in an
aqueous liquid that contains many proteins, lipids, and other colloids. Blood averages
48% blood cells by weight with greater than 95% of the cells being erythrocytes. Blood
exhibits non-Newtonian rheological characteristics unrelated to coagulation or clotting
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as the apparent viscosity decreases with increasing shear rate; as blood flows more
quickly the apparent viscosity decreases, an effect known as shear thinning.26
Manipulating viscous samples containing cellular targets in fluidic vias, most commonly
microfluidic vias, can be accomplished by establishing a pressure differential or by
initiating an electrokinetic flow characterized by either a parabolic or flat profile,
respectively.
1.2.1 Electrokinetic Pumping. Glass and fused silica-based substrates have been
used extensively in microfluidics for performing bioassays due to its well defined surface
chemistry.27 The presence of these surface silanols in glass and fused silica generates
a movement of the bulk solution when an electric field is applied to the fluidic conduit
that moves from the anode to the cathode.28-32 This transport phenomenon is due to the
electroosmotic flow (EOF). EOF is brought about when the negatively charged surface
that results from the deprotonation of silanols attracts cations forming both a fixed and
diffuse mobile layer. The immobile layer is closest to the wall, and adjacent to positive
ions separated by a plane of shear. The potential difference across this plane is termed
the zeta potential. The zeta potential (ζ) is given by:
ζ = 4πδe/є

(1)

where δ is the double layer thickness, e is the charge per unit surface area, and є is the
dielectric constant of the buffer. The mobile layer is carried towards the cathode under
applied electric fields dragging the bulk solution along with it. The magnitude of the EOF
in glass is typically greater than the electrophoretic mobility of most analytes. The EOF
ultimately leads to migration of all positive, neutral, and negative charged components
towards the cathode in that respective order. This type of pumping is typically not ideal

19

for high fluid throughput fluid processing due to its potential for developing voids within
the buffer resulting from O2 and H2 evolution at the electrodes.33,34
While glass and fused silica have relatively large EOF values at high pH values, the
situation for polymer-based materials is ill-defined. Different polymeric material as well
as the treatment imposed on those materials can dramatically affect the surface
chemistry and therefore, produce significant variations in the EOF.

In addition,

decreases in the number density of ionizable surface groups results in significantly
lower EOFs in polymers relative to glass-like materials.24,35
Our research group has successfully overcome this obstacle by applying chemistries
for surface modification of poly(methyl methacrylate), PMMA, and polycarbonate, PC.3538

The potential exists to photo-oxidize polymer surfaces by UV exposure, which result

in increased EOFs due to increases in the surface charge density, while not disturbing
the integrity of the bulk polymer.36,37,39 The formation of phenyl salicylates and
hydroxybenzophenones as well as other hydroxyl and keto containing groups result on
the surface of UV irradiated PC. UV irradiation induces photo-oxidation at the surface of
PMMA forming hydroxyl functional groups.37
Witek et al. reported on the use of polymeric microfluidics for the electrokinetic
transport of E. coli and S. cerevisiae to examine the effects of surface chemistry on the
apparent mobility for pristine and UV modified poly(methylmethacrylate) and
polycarbonate microdevices at varying ionic strengths.33 The electrokinetic transport of
differing cell types was presented in which the potential for separating cells based on
their intrinsic electrical properties was discussed. The magnitude and direction of the
apparent mobilities were determined. The fastest electromigration was exhibited by S.
cerevisiae in a 0.5 mM PBS buffer in a UV-modified microchannel with an apparent

20

mobility reported to be 4.83 ± 0.80 × 104 cm2 V-1 s-1, and a velocity of E. coli in pristine
PMMA equal to -1.04 ± 0.04 × 104 cm2 V-1 s-1.
1.2.2 Hydrodynamic Pumping. Hydrodynamic pumping results from a pressure
differential and is characterized by a parabolic profile and this type of pumping is
prevalent in high throughput applications owing in part to the ability of mechanical
pumps to deliver fluids at well regulated flow rates into high head pressure conduits. In
addition, all material move in one direction irrespective of their chemical composition.
Another problem avoided by hydrodynamic pumping is Joule heating, which results from
resistive heating of the buffer due to current flow and poor heat dissipation. However,
hydrodynamic transport generates large pressure drops for long conduits with small
inner diameters. The pressure drop is directly proportional to the length of the conduit,
flow rate of the solution, and the kinematic viscosity of the solution. The pressure drop
(∆P) across any conduit can be determined using Poiseuille’s Law:
∆P = 8LQη/πR4 (2)
where L is the length of the conduit, Q is the flow rate of the fluid, η is the kinematic
viscosity of the fluid, and R is the conduit radius. From Poiseuille’s equation, it can be
seen that the radius has an inverse exponential effect on ∆P. As an example of the
throughput potential afforded by hydrodynamic pumping, Adams et al. demonstrated the
ability to hydrodynamically process solutions through a micro-conduit at velocities as
high as 100 mm s-1 with no device failure due to the high pressure drop generated
under these conditions.24
1.3 Composition of Microfluidic Devices
In the production of microdevices for any particular application, the fabrication
technique required by the material and the associated cost of the material has to be
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considered. For example, when considering clinical assays, sterile materials are
required for each assay and the ability to use the same device for multiple samples is
not possible due to carryover artifacts. Therefore, low-cost and easy manufacturable
devices are ideal. As a result, polymers are attractive substrates because replicationbased processes can be used to mass produce devices at low-cost.
Various applications require alternative substrate material. In choosing materials for
microfluidic devices, the following should be considered; (i) thermal and electrical
properties, (ii) analyte and matrix chemical compatibility, (iii) availability in pure form at
an affordable cost, (iv) excellent optical properties in the measurement range, (v)
amenable to surface functionalization, (vi) applicable to mass-production using simple
fabrication techniques and (vii) the fabrication technique can produce the requisite
structures for the intended application.
There exist significant cost advantages associated with polymeric microfluidics using
currently available techniques that involve the production of a metal mould with positive
relief structures that can be used to produce structures within a polymeric material.
Commonly used techniques for producing parts from metal moulds include casting, hotembossing, and injection moulding.
1.3.1 Polymeric Substrates. Hot embossing and injection moulding are common
modalities for producing polymeric micro-parts and can produce fluidic layouts with high
aspect ratio microstructures (HARMS).39

Details of hot embossing and injection

moulding are discussed in detail elsewhere.40-42 Briefly, hot embossing involves the
transfer of a positive structure, termed a mould insert/master, to a substrate under
precisely controlled temperature and pressure. The substrate is typically heated to
above the glass transition (Tg) temperature of the polymer, and an applied force in the
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range of several thousand Newtons. The Tg of a polymer indicates the temperature at
which the polymer begins to flow due to the thermally initiated breaking of non-covalent
bonds between the polymer chains. The application of significant force ensures that the
polymer fills the mould cavity completely facilitating the high fidelity of reproducing
microstructures.39,43
Conventional mold inserts are prepared via lithographic techniques that require
radiation sources such as x-rays or UV light and electroplating to produce the mould
master. For example, UV and/or x-ray LiGA can produce structures in the
submicrometer regime with aspect ratios exceeding 20 or more, but involves 10 – 14
steps to go from concept to final product (see Table 1.1).42 Alternatives, such as high
precision micromilling, has fewer processing steps but can only produce structures with
lateral dimensions on the order of 20 µm and aspect ratios of 5. However, mould
fabrication only requires a few processing steps.

Table 1.1 Comparisons of Manufacturing Techniques for Microfabrication.
Characteristics
LiGA – X-ray
LiGA – UV
Micromilling
Minimum size

20 nm

500 nm

20 μm

Multilevel

1

3 or less

5 or less

Aspect ratio

100 or more

20 or less

5 or less

Side-wall roughness

1-10 nm

20-50 nm

>150 nm

Production cost

$$$

$$

$

Processing steps

14 steps

10 steps

4 steps

Turnaround time

2 weeks

1 week

< day
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In contrast to glass-based microdevices, polymeric microdevices have relatively low
EOF resulting from a reduction in the number density of ionizable surface groups.
Additionally, polymers have lower occurrences of cell adhesion on pristine surfaces due
to the low surface charge density of polymers.38 The decrease in ionizable surface
groups results in significantly lower EOFs in polymers relative to glass-like
materials.24,35 The apparent mobility (μapp) consists of two components:
μapp = μEOF + μEP

(3)

where μEOF is the mobility arising from the EOF and μEP is the mobility component
arising from the electrophoretic mobility of the analyte. According to equation 3, the
apparent mobility is the sum of the electrophoretic and electroosmotic mobilities. The
EOF component is contingent upon buffer conditions and the microchannel surface
chemistry. Our research group has generated novel surface modification chemistries of
poly(methylmethacrylate), PMMA,

and polycarbonate, PC, to increase the number

density of ionizable groups.35-38 The application of said surface modification chemistries
is effective at increasing the number of ionizable surface groups, while not disturbing
the integrity of the bulk polymer.36,37,39
1.4 Macro-Scale Techniques for Analyzing CTCs
Macro-scale CTC techniques possess the ability to process input volumes
exceeding ~5 mL, which is attractive due to the extremely low abundances of these cell
types in clinical samples, The commonly used macro-scale formats for enriching CTCs
from clinical samples include: (i) Magnetic capture using micrometer-scaled
ferromagnetic beads coated with molecular recognition elements in macro-scale
vessels;20,44,45 (ii) size-based separations using tracked membranes;19,46,47 (iii) flowassisted cell sorting;9,46,48 and (iv) reverse-transcription of mRNAs that are used as
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chemical surrogates for tumor cell identification.49,50 Macro-scale techniques for cell
processing and selection are typically performed using samples with volumes >1 mL. In
the following sections, these macro-scale processing techniques for identifying the
presence of tumor cells in clinical samples will be discussed as well as variants of these
basic cell selection processes.
1.4.1 Immunomagnetic Affinity Capture (IMAC). Balic et al. evaluated two
commercially available immunomagnetic isolation kits for selecting CTCs from
peripheral blood samples of metastatic patients.15 Both kits employed anti-epithelial cell
adhesion molecules (EpCAM) antibodies for selecting the cancer cells. Twenty-two and
one half mL aliquots of blood were taken from each patient with a 15 mL aliquot used
for the OncoQuick® system and the remaining 7.5 mL used for the CellSearch®
procedure. Both procedures employed density gradient centrifugation followed by a
series of washes in order to remove the RBC fraction from the whole blood sample prior
to magnetic isolation of the CTCs. Centrifugation of the RBC depleted sample was next
performed at 800×g for 10 min to remove the blood plasma. The resulting cellular
pellets were resuspended in 10 mL of buffer, and incubated with carboxylatefunctionalized

ferromagnetic

particles

that

were

coated

with

anti-EpCAM.

Immunomagnetically-labeled cells were concentrated using an external magnetic field.
Following magnetic isolation, the processed sample was incubated with leukocyte
specific anti-cytokeratin antibodies labeled with Alexa Fluor 555, nuclear specific 4’,6diamidino-2-phenylindole (DAPI), and a CTC specific anti-EpCAM antibody conjugated
to a fluorescein derivative. Under these conditions, white blood cells and tumor cells
harbor blue fluorescing nuclei; however, the fluorescent signatures of the FITC
derivative selectively placed a green “halo effect” about the blue nuclei of the CTCs.
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The orange fluorescent halo from the Alexa Fluor 555 about the nuclei of the leukocytes
was used for exclusion.

100
90

OncoQuick (15mL Blood Tested)
CellSearch (7.5mL Blood Tested

Positive Samples, %

80
70

60%

60
50
40
30

26%

20

12%

12%

10
0
Metastatic

Non-Metastatic

Figure 1.3 CTC recovery results from commercially available immunomagnetic cell
isolation strategies from 61 metastatic cancer patients and 8 controls samples that were
absent of any form of disease. Reprinted with permission.15
The CTC recovery rates using both kits from cancer patients with metastatic disease
and healthy donors are shown in Figure 1.3. Data from 53 cancer positive samples
(Metastatic, see Figure 1.3) are shown on the left as evaluated by CellSearch and
OncoQuick. The data indicated that the recovery of the CTCs was significantly better
using the CellSearch system (60% recovery) compared to the OncoQuick system (26%
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recovery). In addition, the CellSearch system required a smaller input volume compared
to the OncoQuick system. The data for non-metastatic samples (see Figure 1.3) with
both kits showed the detection of at least one CTC in the blood of healthy individuals in
12% of these samples analyzed. For the confirmed metastatic cancer cases, CellSearch
was capable of producing positive responses in 54% of these samples resulting in a
relatively high rate of false negatives.48 The OncoQuick system demonstrated poorer
detection accuracy as only 23% of the samples were reported positive for metastatic
disease. In 5 of the 6 varieties of cancer studied, CellSearch was twice as effective as
OncoQuick at detecting metastatic disease and CellSearch was also found to be more
sensitive in common positive tests often identifying more CTCs within similar amounts
of peripheral blood.
1.4.2 Sized-Based Separations. Tracked polycarbonate membranes with varying pore
sizes (8 – 14 µm) have also been employed to filter large (9.0 – 18 mL) blood samples
spiked with known quantities of CTCs.51 Prior to filtration using the membrane, the
samples were diluted at a 1:1 (v/v) ratio of spiked blood:PBS containing an
anticoagulant (ethylene diamine tetra acetic acid). Simple gravimetric filtration through
these polycarbonate membranes is sufficient to reduce the erythrocyte content by >105
cells mL-1. After the initial filtration using the polycarbonate filter, the isolated cells are
washed and incubated for 1 h with anti-pan-cytokeratin directed against cytokeratin 5, 6,
8, 17 and 19)-FITC. After a wash to remove the unbound anti-cytokeratin antibodies,
nuclei-specific propidium iodide is added, and an additional incubation of 30 min
performed. The cells retained by the polycarbonate membrane are analyzed using a
combination of laser scanning cytometry (LSC) and microscopy. After analysis, all the
cytokeratin positive cells are relocated and examined “by eye” to exclude any false27

positive events. Only positive cells with the appropriate nuclear:cytoplasmic ratio were
counted as positive events. False positives were evident in the case of MCF-7 cells, and
the authors attributed this to the presence of adhesion molecules on the cells’ periphery.
The most prominent reduction in leukocyte frequency was demonstrated for 9 mL blood
samples that originally contained 50,000,000 leukocytes, which was reduced to 7,000
leukocytes after the filtration step. These membranes were demonstrated to isolate
nearly 85 – 100% of the CTCs, but significant numbers of white blood cells were also
retained due to their similar size with respect to the CTCs complicating the enumeration
process. Also, the process requires pre or post treatment of retained cells with a variety
of fluorescent stains before the LSC could be utilized.
Microarrays have also been used in the isolation of target cells. Various “cluster of
differentiation” (CD) antigens are affinity-captured onto the arrays containing
immobilized antibodies.52 The arrays contain several surface-immobilized antibodies
directed toward target antigenic species, which are used to spatially isolate cells. These
methods are limited by slow mass transport but are promising for multiplexed analyses;
the array elements are not individually addressable making collecting isolated cells from
a multiplexed analysis difficult due to the single chamber of the arrays. Most often in
order to isolate a particular phenotype, subsequent processing is required.

Belov

et

al. presented an array technique based on cluster of differentiation in leukemia.52 The

CD antigens could be used to phenotype leukocytes based on characteristic abnormal
patterns of antigen expression. Microarray technology has also been used to screen
HIV positive blood against normal as well as blood from those undergoing therapy and
those deemed long term non-progressors.12
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1.4.3 Fluorescence Activated Cell Sorting (FACS). Gross et al. employed FACS to
sort spiked breast cancer cells from a BT-20 cell line that were seeded into peripheral
blood mononucleated cells (PBMC or WBC) at frequencies of 10-5, 10-6, and 10-7.9 The
PBMCs were suspended in PBS buffer with 20% fetal calf serum. To the PBMC (cell
count = 4 × 108) suspensions were added 10, 100, and 1,000 BT-20 cells. The flow
cytometer employed three excitation sources; 325 nm, 488 nm, and 633 nm allowing for
discrimination between the PBMCs and BT-20 cells via immunoaffinity staining. A panel
of fluorescently-labeled antibodies specific for the PBMCs produced a green color for
these cell types. Another panel of immunofluorescent markers were used for the BT-20
cells, that produced a yellow color and 2 shades of red, but no green color for these
cells.
The extensive cell staining procedure is briefly listed here. The BT-20 cells were
stained with a blue fluorescing dye, 7-amino-4-chloromethylcoumarin (CMAC) before
seeding these cells into a PBMC suspension. BT-20 breast cancer cells were also
characterized by a cocktail containing three anti-cytokeratin antibodies, each tagged
with a different colored dye. Leukocytes were identified with monoclonal antibodies
labeled with a fourth dye. All cells were incubated for 1 h in 150 µL of an exclusion
staining cocktail containing 20% normal mouse serum. The following fluorescein
isothiocyanate (FITC) conjugated antibodies were added to the suspension: 14.9 µg of
anti-CD45 HLe1-FITC per mL; 54 µg of anti-platelet glycoprotein (gpIX) (CD42a)-FITC
per mL; 56.6 µg of anti-pan-platelet (CD61)- FITC per mL; 2.2 µg of anti-CD34 HPCA-2FITC per mL; and 0.7 µg of anti-glycophorin-FITC per mL. Subsequently, a staining
cocktail containing 25% normal mouse serum and the following anti-cytokeratin
antibodies conjugated to peridinin chlorophyll protein (PerCP), phycoerythrin (PE) or
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allophycocyanin (APC): 2.6 µg of NCL-5D3 anti-cytokeratin components 8 and 18
conjugated to PerCP per mL were used; 1.8 µg of NCL-LP34 anti-cytokeratin
components 5, 6, and 18 conjugated to PerCP per mL; 0.27 µg of CAM 5.2 anticytokeratin components 8 and 18 conjugated to PE per mL; and 1.43 µg of AE1 anticytokeratin components 10, 14, 15, 16, and 19 conjugated to APC per mL. The data
were prefiltered, eliminating events negative for FITC but positive for PE, PerCP, and
APC. In all instances the goal was to locate events characterized by fluorescence from
FITC, PE, PerCP, and APC, which were used as positive signals for the BT-20 cells.
Using a color discrimination algorithm, the authors were successful at detecting rare
BT-20 cells with 20% recovery with cancer cell frequencies of 10-5 and 10-6. However,
the authors indicated that ~200 mL blood sample volumes would be needed to reliably
assess rare CTCs in the presence of 108 PBMC cells at frequencies of 10-7. The
challenges associated with this assay format is the extensive amount of time required
for the immunofluorescent staining (~20 h), the need for removing the RBCs from the
blood sample prior to processing and the equipment required for the measurements.
1.4.4 Reverse Transcription Polymerase Chain Reaction (RT-PCR). Another
approach for the analysis of CTC presence in peripheral blood is the use of reversetranscription polymerase chain reaction (RT-PCR), in which mRNAs are used as
surrogates to report on the presence of CTCs. This gene expression based assay has
high sensitivity, but poor selectivity which leads to false positives. Often nested PCR is
performed in which multiple rounds of the PCR amplification are performed in order to
generate signal. Reports have documented the ability to detect low numbers of CTCs in
106 PBMCs using an appropriate marker panel set.50 When expression profiles of
healthy females were compared to breast cancer patients, elevated median levels of
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three of the markers comprising this panel (p1B, PS2, CK19, and EGP2) were found
(see Figure 1.4).

Figure 1.4 RT-PCR expression profiling results for three genetic markers overexpressed in tumor cells p1B (A), CK19 (B) and EGP2 (C). In this study, 103 breast
cancer and 96 normal patients were evaluated. The horizontal line presents the median
expression level for each group. In all cases, only the PBMC fraction was analyzed
using RT-PCR. The number of PCR cycles performed depended upon the expression
level of each marker, but ranged from 0-50 cycles. Reprinted with permission.50

Though RT-PCR is highly sensitive and specific when employing multiple markers in
the expression profiling, securing morphological data on the CTCs is not possible
because the cells are sacrificed to obtain the mRNA markers used in the assay. As with
many CTC-based assays, the RBC fraction of the blood sample must be removed using
for example, Ficoll-Hypaque density gradient centrifugation. In addition, the expression
level of the marker genes cannot be related to the absolute number of tumor cells within
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the sample. Finally, it has also been noted that these assays are prone to high interlaboratory variability.
1.5 BioMEMS and µTAS Devices for Sorting CTCs
Near the turn of the 21st century the concepts of biological microelectromechanical
systems (BioMEMS) or miniaturized total analysis systems (µTAS) were introduced as a
means of processing many biological samples, such as on-chip cell sorting.27 BioMEMS
typically consists of several subcomponents incorporated into a single device that can
sample, pretreat, analyze, and detect the material of interest ideally from a raw sample.
To some extent, experiments in microdevice electrophoresis using planar substrates by
Manz and Harrison in glass devices in the early 1990’s set forth the cascade of events
that have resulted in advancements in the application of BioMEMS devices in the
analysis of cells.34

Figure 1.5 Microfabricated flow chip demonstrating directed pressure-induced cell
manipulation. Reprinted with permission.53
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As mentioned previously, glass and polymers have been used extensively as the
substrate materials for BioMEMS devices; manufacturing strategies for glass or
polymers vary greatly. Early microfluidic devices were dominated by the use of glass
substrates, primarily because the surface chemistry of the material was well studied.35
For

BioMEMS

devices,

hydrodynamic,53,54

electroosmotic,55,56

and

dielectrophoretic57,58 forces have been employed to manipulate and manage biological
cells. Blankenstein et al. demonstrated the use of differential pressures to manipulate
fluids into any one of five channels as shown in Figure 1.5.53 At the inlet, the sample
was introduced into the device and conduits C1 and C2 were used to guide the sample
to outlets 1 – 5. This work illustrated a couple interesting points: (i) directed flow could
be achieved with simple instrumentation and (ii) fluid mixing on the micrometer scale
was not a rapid process.

Figure 1.6 Baker’s yeast cells are electrokinetically manipulated through a glass
microdevice. Reprinted with permission.59
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Electrokinetic transport was demonstrated in glass microchips by Li et al.59 In these
experiments, Li was able to alternate the electro-migratory path of the cells by switching
the path of current flow resulting in a directional gate dictating the track followed by the
cells through the glass microchips as shown in Figure 1.6. Velocities of 0.054 ± 0.005
mm s-1 and 0.28 ± 0.05 mm s-1 were achieved at field strengths of 35 V cm-1 and 140 V
cm-1, respectively, through a 15 × 55 μm2 cross sectional area. Referring to Figure 1.1,
a channel with a cross section of 825 µm2 and a velocity of 1 mm s-1 with a sampling
volume of 1 mL would require ~1600 h to complete the analysis.

Figure 1.7 Furdui et al. presented a magnetic cell isolation strategy adapted to
microfluidic platforms. A syringe pump was used to transport suspensions through a
magnetic zone where immunomagnetic isolation occurred. Reprinted with permission.20
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Furdui and Harrison adopted immunomagnetic techniques onto microfluidic
platforms in order to enrich Jurkat cells (T cell leukemia) from blood, and their apparatus
is shown in Figure 1.7.20 The model samples used Jurkat cell:erythrocyte cell ratios of
1:10,000 with a total of 1-2 × 1010 RBCs mL-1 with a Jurkat cell frequency of 1 x 106 per
mL. The authors removed the leukocytes from the blood prior to the microfluidic
analysis. The magnetic beads were initially functionalized with protein A prior to
incubating with anti-human CD43. The results of the incubation yielded antibodyfunctionalized beads, where the antibodies were bound to protein A via their Fc domain.
A magnetic zone was used to selectively isolate the magnetic particles bound to the
target cells in the microfluidic device. Subsequent to a rinsing step, the captured cells
were eluted after removal of the magnetism and initiation of hydrodynamic pumping.
Following optimization, the authors were able to isolate 37% of the spiked T-cells with a
throughput that corresponded to 3 μL min-1 from a 2 µL sample that consisted of 1,070
Jurkat cells.
Becker et al. extended dielectrophoresis to mixtures of MDA231 breast cancer cells
(1 × 107 mL-1) and normal blood cells (3 × 107 mL-1).60 In their work, 30 µL aliquots of
the suspensions were applied to a dielectrophoresis chamber. The total number of cells
analyzed was 1.2 × 106 with a ratio of 1:3 tumor cells to normal hematopoietic cells.
Upon 3 analyses of each sample, they were able to increase the ratio of cancer cells to
normal cells from 1:3 to 1:1 for 10,000 cells analyzed. Analyte loss was prevalent in
their work, in that of the cancer cells originally introduced into the device, only a small
percentage (3.33%) of the targets were successfully isolated. It is important to note that
typically cancer cells appear at a much lower ratios than those used in these model
studies; ratios of 1:108 cancer cells to normal blood cells are typical.
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Mohamed et al. demonstrated the potential for size-based by developing a
microfluidic incorporating staggered microposts with incrementally decreasing spacing
between the posts as shown in Figure 1.8.19,22 The size-based isolation of cancer cells
was carried out using diluted blood (1:10 blood:buffer) containing neuroblastoma cells.
The authors demonstrated the ability to isolate neuroblastoma cells however, the
authors did not state the capture efficiencies of the cancer cells using this device. In
addition, the enriched cells obtained from the device had low purity with residual
erythrocytes and leukocytes also collected within the cancer cell sample.

Figure 1.8 Scheme of size based cell separation device presented by Mohamed et al.
Reprinted with permission.22
Chang et al. presented a device produced in glass using deep reactive ion etching
(DRIE) that incorporated a microchannel that was 10 mm long, 500 μm wide and 40 μm
deep with an array of square or offset posts that were 25 × 25 μm2 or 35 × 10 μm2,
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respectively.17 The device structures were coated with E-selectin IgG chimera
antibodies. Pure suspensions of two myeloid cell lines, HL-60 and U-937, were used to
evaluate the ability of the microfluidic platforms to isolate cancer cells using this
biomemetic approach. The suspensions reportedly used in this study were on the order
of 106 cancer cells mL-1, well above a cell density typically associated with clinical
samples harboring CTCs. The authors reported a volume throughput of 1 μL min-1,
which would require 16.7 hrs to process 1 mL that may be necessary if the cell
frequency is more in lines with actual clinical samples. Also, the authors indicated that
favorable cell capture efficiencies were achieved when the device surfaces were coated
with immobilized cells. Adams et al. demonstrated that throughput suffers when
maximizing capture efficiency; however, it is unrealistic to process 1 mL sample sizes
for 16.7 hrs. Chang and coworkers acheived capture efficiencies of 64% even though
the duration of the experiment was lengthy.
Dielectrophoresis is a phenomenon, first detailed in the early 1950s, which involves
the translational motion of uncharged dielectric particles by non-uniform electric fields.61
Depending on the electrode configuration and geometry used to produce the AC electric
field, as well as the magnitude and phase variations of this field, cell-based separations
can be affected using dielectrophoresis. Gravimetric field flow fractionation is the
process by which particles are allowed to settle while under the influence of an axial
flow based on their inherent interaction with gravity.62 Yang et al. combined the two
techniques to separate cells based on the balance between the composite
electrophoretic mobility and the gravimetric attraction of the cells to settle on the device
floor.63 A schematic of the apparatus used in the work by Yang et al. is shown in Figure
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1.9. Results suggested that a breast cancer cell line (MDA-435) could be separated
from erythrocytes in a 10 μL sample containing ~50,000 cells total.

Figure 1.9 Field flow fractionating device was presented by Yang et al. in 1999.
Reprinted with permission.63

The enriched fractions of the MDA-435 cells and erythrocytes were reported to be >98%
and >99%, respectively, from 15 fractions collected over a 30 min elution time. The final
concentration of MDA-435 cells in the buffer processed was reported to be 5 × 106 cells
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mL-1 at a nominal ratio of 2:3 of cancer cells:erythrocytes. The authors noted a 20 min
distinction between elution times of the erythrocytes and cancer cells, but the model
sample in this experiment did not harbor leukocytes. Leukocytes are significantly larger
than erythrocytes and thus, could impart interference in the measurements.

Figure 1.10 Diagram of Simonnet’s flow cytometry device and the proposed focused
region of high-probability density of analyte location. Reprinted with permission.64

Simonnet et al. attempted to port conventional high throughput, high resolution cell
sorting using flow cytometry to a poly dimethylsiloxane microfluidic platform.64
Conventional flow cytometry is characterized by typical flow rates of ~10 m s-1
corresponding to sampling rates of 1,000 – 50,000 cells s-1. In order for a microfluidic to
be considered suitable replacement for flow cytometer, it would have to approach this
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threshold in terms of the linear velocity. A diagram of Simonnet’s device is shown in
Figure 1.10. Briefly, flow was from left-to-right in the diagram and a cross flow was used
to hydrodynamically focus both opposing sides of the region labeled E in Figure 1.10C.
Using this platform the authors were able to count cells consistently at 1,200, 9,000, and
17,000 particles s-1. As the flow rate was increased the particle number increased and
so did the coefficient of variance (CV) in their measurements. At 1,200, 9,000, and
17,000 particles s-1 the CVs were 3, 7.6, and 11%, respectively. Remarkably, the CV
values for the microfluidic device rivaled those of the commercial instrument for the
same sample set. As with the macro-scale version of the flow cytometer, to sort and
enumerate the low abundant CTCs, specific staining protocols will need to be invoked
as well as some sample pre-processing prior to flow assisted cell sorting.9

Figure 1.11 Poly dimethylsiloxane microstructures with valves for used for cell isolation.
Reprinted with permission.25
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Valves, actuators, and mechanical trapping of cells using moving parts within a
closed microfluidic network is possible when casting elastomers, like polydimethylsiloxane, against positive reliefs.25 Pressure from fluids or air are commonly
used to open and close valves within microfluidic networks resulting in temporarily
trapping or redirecting the flow path of cells and or fluids within the device. Irimia and
Toner produced a device with features designed to accomplish the manipulation of
human monocytic leukemia cells in a microfluidic device.25 In this work, 30 nL aliquots of
human monocytic leukemia cells were use to prepare suspensions with densities
ranging from 1 × 103 to 1 × 107 cells mL-1. The enrichment was reported to be ~1,000fold. Figure 1.11A shows a diagram of an actuated valve and subsequently trapped cell
and Figure 1.11B and C show actual cells being temporarily isolated on a membrane
and transported to a membrane, respectively. Figure 1.11D shows the effectiveness of
the cell isolation technique by demonstrating the enrichment potential as a function of
the input cell density.
Nagrath et al. isolated rare CTCs from blood samples using microfluidic devices
that contained 78,000 microposts that were 100 µm tall and 100 µm wide in a total area
of 970 mm2.5 At flow rates of 1 mL hr-1, 65% of CTCs were isolated from spiked PBS,
and as the processing flow rate was increased to 3 mL hr-1 the recovery rate was
reduced to 25% as shown in Figure 1.12. In whole blood measurements, approximately
2.7 mL of blood was used and the CTC recovery rates were typically 61%. Enrichments
from whole blood samples were ~50% pure after analysis and as a result, CTCs had to
be differentiated from leukocytes, the main interferent, using fluorescently-labeled
cytokeratin and CD45 (see Figure 1.12). Twenty healthy subjects served as controls
and those samples evaluated negative for CTCs.
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Figure 1.12 Capture efficiency as a function of (A) flow rate, (B) cell line, and (C) spiked
cells are shown along with typical micrographs of the stained cells where (D – G) show
an event that is positive for cytokeratin and DAPI attributed to a CTC and (H – K) show
a cell positive for DAPI and CD45, which is indicative of a leukocyte. Reprinted with
permission.5
42

Figure 1.13 Shevkoplyas et al. presented a micro-separation device capable of
significant leukocyte enrichment. Reprinted with permission.65
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Shevkoplyas and coworkers presented a microfluidic that was capable of a 34-fold
enrichment of white blood cells from samples that contained cell densities of 2,100 cells
μL-1 to 42,300 cells μL-1 using a 10 μL whole blood sample (see Figure 1.13).65 Whole
blood enters the device through a 70 μm supply channel. The histograms in Figure 1.13
show that initially the cells are evenly distributed throughout the channel, but as smaller,
more deformable erythrocytes seek the faster flow region in the center of the channel,
the lumen of the erythrocytes collide with leukocytes forcing them to migrate toward the
walls. The branching nature of the device provided selectivity for large cells, such as
leukocytes, that migrate through the device at the walls, while erythrocytes migrate
through the center of the device. Ultimately, the effluent shown in zone 8 of Figure 1.13
has a 20-fold increase in leukocyte density from the original input. Unfortunately, the
process was marred by significant numbers of contaminating erythrocytes, and the
potential for handling large input volumes required for scoring the presence of lowabundant cells was not possible due to the constricted flow after the third bifurcation in
the analyte channel.
Adams et al. introduced a high throughput microsampling unit capable of meticulous
selecting very low abundant targets from complex media.24 In their work, a microfluidic
device composed of poly(methylmethacrylate) employing many parallel high aspect
ratio microstructures was functionalized via UV exposure providing a carboxylated
scaffold amenable to antibody immobilization. The immunoslection of the cells was
affected through the use of monoclonal antibodies specific for the epithelial cell
adhesion

molecule

(EpCAM),

which

is

over-expressed

in

a

number

of

adenomacarcinomas. The immobilized antibodies were used to selectively isolate low
abundant MCF-7 breast cancer cells through a cascade of antibody:antigen complex
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formations sufficient to remove the cells from unprocessed whole blood with 97%
recovery efficiencies. The devices were capable of high throughput operation at the
optimal capture velocity of 2 mm s-1 such that 1 mL samples could be exhaustively
interrogated in approximately 37 min. Further, these devices required no sample
pretreatment by removing the red blood cell fraction via centrifugation or fluorescent
staining of the cells due to on-chip integration using a conductance-based sensor
capable of discriminating wild-type cells from the low abundant cancerous targets with
near 100% detection efficiency.

Table 1.2 Figures of Merit for CTC Isolation on Macro and Micro-Scale Platforms.
Cell Isolation Methods
and Description

Preprocessing
Requirement

Throughput

Sample
Purity

Enumeration

MagnetophoreticImmunoaffinity20

Density
gradient
centrifugation

High
(mL/min)

Low
(40-60%)

OfflineFluorescence

Nuclear Tracked
Membranes51

Dilution

High
(mL/min)

Medium
(60-80%)

OnlineFluorescence

FACS/MACS11,12

Density
gradient
centrifugation

High
(mL/min)

Medium
(60-80%)

OnlineFluorescence

Microposts5,19,25

Dilution

Low
(μL/min)

Low
(40-60%)

OfflineFluorescence

HTMSU24

--

High
(mL/min)

High
(> 90%)

OnlineConductivity

The analytical figures of merit for several different cell isolation strategies are
detailed in Table 1.2 outlining the advantage and disadvantages for each of the various
approaches for isolating CTCs from complex biological samples, such as whole blood.
Included in this table are two representative microfluidic platforms directed toward rare
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cell isolation. As can be seen from this data, the HTMSU example can process large
input volume samples with high recoveries and also, due to the incorporation of the
conductivity sensor, does not require cell staining for enumeration.
1.6 Future of Microfluidics
Of the various cell isolating/sorting tools developed to-date, some common
procedural characteristics make many of them prohibitively difficult to implement; such
as, the ability of many of the platforms to only sort the mononucleated cell fractions of
whole blood. This criterion dictates the need for performing density gradient
centrifugation prior to the enrichment procedure. In addition, these methods often have
low throughput such that the probability of isolating the rare event is reduced due to the
device capabilities of processing less than 50 µL of sample. Subsequently, the use of
either fluorescence activated cell sorting or fluorescence microscopy is performed such
that the target cells can be enumerated. This adds additional sample processing of the
enriched CTCs via reactions with combinations of fluorescent markers. These
supplemental steps necessitate sample handling and transfer, which can induce CTC
loss or introduce contamination that can dramatically affect the assay results. This is
especially prominent when dealing with low frequency events. To date there have been
only two reports of self-contained systems capable of meticulously separating intact
CTCs from peripheral blood samples allowing for the direct quantification of the CTC
levels once enriched.5,24
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Chapter 2 Cell Transport via Electromigration in Polymer-Based Microfluidic
Devices
2.1 Introduction
The ability to fabricate microscale analytical devices on planar substrates with
dimensions similar to those of biological cells has recently attracted significant attention
in the field of bioanalysis (i.e., identification and quantification of specific cellular
contents, such as DNA, RNA, or protein). Microfluidic devices are attractive for cellular
analyses since many processing steps can be integrated into a single platform,
minimizing dilution of intracellular components following lysis. The feasibility of handling
biological cells in microfluidic devices using various physical forces has already been
demonstrated in glass.1-5 Cell transport and sorting on microfabricated devices have
been reported where hydrodynamic,4,6 electroosmotic,2,7 and dielectrophoretic8,9 forces
have been used. For example, Li and Harrison2 used electroosmotic pumping in glass
microdevices to transport cells within a network of channels. On-chip manipulations
such as plug formation and flow switching in the channel were demonstrated. Chang et
al.10 performed electrical characterization of microorganisms in microdevices.
Electrophoretic movement of live and heat-inactivated bacteria confirmed the presence
of negative charges on the surface of the cell membrane of the live microorganisms.
The dead cells accumulated at the negative electrode suggesting alteration in the
charge state of the cells upon heat inactivation. Cell lysis, PCR amplification, and
electrophoretic analysis of the genetic amplicons were executed sequentially on a
monolithic glass microchip by Waters et al.3 The entire microchip was thermally cycled
to lyse cells and to amplify the DNA, which was carried out in a fabricated well located
on the chip. Heo et al.11 entrapped viable E. coli cells in hydrogel micropatches within
microfluidic systems. Small molecules, such as dyes and surfactants, were able to
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diffuse into the gel, which caused cell lysis and released the cell contents. The cell
debris, being sufficiently large, was retained within the gel matrix.
The majority of research on cell transport and manipulation performed in
microdevices has been done primarily in glass or silicon. Glass offers important features
for cell transport because the EOF is very well characterized and has a magnitude that
is typically greater than the electrophoretic mobility of most analytes, leading to
migration of all materials, irrespective of charge, toward the cathode. The large
electroosmotic flow in glass is due to the high surface charge of this material (i.e.,
deprotonated silanol groups).
Polymers are viewed as attractive materials for microfluidic devices due to their
flexibility in micromanufacturing structures, ability to pattern high aspect ratio
microstructures, and the low cost of replicating daughters from masters using
embossing

or

injection

poly(methylmethacrylate),

molding.12
high

and

Unfortunately,
low

density

many

polymers

polyethylene,

(e.g.,

polystyrene,

polypropylene, polycarbonate) do not contain ionizable functional groups and, as such,
produce much smaller EOFs compared to glass.13,14 In terms of cell transport, small
EOFs can be problematic due to a lack of well-defined transport control.
The EOF, however, can be altered by chemical modification of the polymer substrate
leading to the introduction of new ionizable groups on the surface. Successful chemical
modification of PMMA and PC has been reported previously in our lab.15,16 The EOF of
amine-terminated PMMA microchannels was shown to be reversed compared to that in
unmodified channels. Another way to modify polymers is exposure to UV light. UV
irradiation causes photo-oxidation, resulting in a thin surface layer of oxidized
polymer.17-20 For example, PC exposed to 254-300 nm light results in the formation of
polymer phenyl salicylates and hydroxybenzophenones.18,19 Also, hydroxyl-containing
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and keto-containing products have been reported.18,19 In general a wide range of
carbonyl-containing functionalities is produced during UV-modification resulting in highly
oxygenated surfaces even though the carbonate groups are depleted. PMMA photooxidation produces alcoholic groups that are both hydrogen-bonded to ester groups,
and/or self-associated.17 Such photo-processes are easy to perform and introduce
additional groups on the polymer surface with fairly high quantum yields. Therefore, UV
exposure of polymers can be viewed as a simple method to induce changes in the
EOF.14,21,22
The goal of the work presented herein was to characterize the electrokinetic
transport properties of whole cells in polymeric microfluidic devices. The channels of the
polymer microdevices were either pristine or UV-modified in order to change the
chemistry of the walls, and consequently changing the EOF. We report on chip transport
and monitoring of bacterial (Escherichia coli) and baker’s yeast cells (Saccharomyces
cerevisiae). Two important analytical features will be presented; (i) control of cell
transport (i.e., flow direction and velocity) by electroosmotic/electrokinetic forces, and (ii)
sorting of Escherichia coli cells from Saccharomyces cerevisiae using differential
migration in appropriately prepared material and buffer conditions.
2.2 Materials and Methods
2.2.1 Cells and Reagents. Baker’s yeast cells type II (Saccharomyces cerevisiae) and
nonpathogenic Escherichia coli type B cells were obtained from Aldrich (Milwaukee, WI).
The stock solutions of phosphate buffer saline (PBS, 100 mM pH=3.0, 7.4, and 9.0,
Aldrich) were reagent-grade quality. Concentrations of 0.5, 1.0 and 20 mM PBS were
prepared by dilution of the stock PBS solution with deionized (DI) water (17.9 MΩ) from
an E-pure water purification system (Barnstead, Dubuque, IA). Cells were washed two
times with DI water and centrifuged (1000 rpm). Next, they were placed in buffer and
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stored in a refrigerator at 4oC until used (≤ 4 hrs). Cell suspensions for baker’s yeast
and E. coli were 0.30 and 0.33 mg/mL, respectively, unless stated otherwise. Before
each measurement, cells were vortexed (Vortex-2 Genie, VWR Scientific, and
Westchester, PA) for ~5-7 min.

Figure 2.1 A) Photograph of a polymer microdevice with 200 µL buffer reservoirs and
interconnects attached to the inlet and outlet ports. Microdevice parameters: channel
length = 4 cm, side channel lengths = 0.5 cm, channel width = 50 µm, and channel
depth = 80 µm. The solid black line represents the device topology. B) Optical
micrograph of a PMMA microdevice channel filled with E. coli and C) baker’s yeast cells
(S. cerevisiae) in 1 mM PBS, pH=7.4. These images were obtained using a 100x
immersible objective. The observed area under the microscope was 60 x 80 µm. The
dotted circles in B) highlight E. coli cells contained within the device.
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2.2.2 Microchip Fabrication. Polymer microchips were fabricated using LIGA as
previously reported.12,23,24 The procedure involved fabricating a metal molding die, which
consisted of raised microstructures of Ni on a stainless steel base plate. The device
used in these studies possessed a 50 µm wide and 80 µm deep channel of 4 cm total
length and configured in a cross with side channels of 0.5 cm in length.
Devices were prepared in polycarbonate (PC) and poly(methylmethacrylate)
(PMMA). PC and PMMA stock sheets of 5.0 mm thickness (Goodfellow, Berwyn, PA)
were cut into 133 mm diameter round disks. Discs were washed with 2-propanol and
distilled water and dried in an oven at 80°C overnight. The microchannel pattern was
hot embossed into the polymer plates using a PHI Precision Press model number TS21-H-C (4A)-5 (City of Industry, CA). A vacuum chamber was installed into this press to
remove air (pressure <0.1 bar) so complete filling of the die could take place.
Embossing was performed at 1000 lbs pressure for 4 min at 190°C for PC and 150°C
for PMMA.
Before final assembly, chips were washed with soap, rinsed with DI water and 2propanol, and then ultrasonicated for 15 min in DI water. The channels were examined
under a microscope to ensure they were not filled with debris. The embossed devices
were assembled by heat annealing a coverplate made from the same material to the
substrate. The coverplate and substrate were clamped together and placed in a
convection oven for ~20 min at 150°C for PC and 105°C for PMMA. After successful
heat annealing, 1 mm holes were drilled into the coverplates and the microfluidic
reservoirs/ports were attached with epoxy resin to the inlet and outlet holes. High
volume reservoirs (~200 µL) minimized loss of buffer due to evaporation and reduced
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the movement of cells due to capillary or hydrodynamic forces. Figure 2.1A shows a
photograph of a fabricated device.
2.2.3 Surface Modification. The hot-embossed PC and PMMA microchannels and
coverplates were modified prior to assembly by exposure to UV radiation (15 mW/cm2)
for 30-40 min using a UV lamp (ABM, Inc., San Jose, CA). After illumination, all of the
polymer parts were rinsed with 2-propanol and sonicated for 5-10 min in DI water. The
devices were assembled also by heat annealing, however, at lower temperatures
compared to the non-exposed materials (144°C for PC and 98°C for PMMA). It was
observed that UV modification of the polymer lowered its glass transition temperature
(Tg), thus requiring a lower annealing temperature.
In an effort to simplify device production a post annealing UV treatment was
attempted, whereby the devices would undergo thermal annealing as detailed earlier
prior to UV modification. In order to test the protocol planar PMMA substrates were UV
modified using incrementally increasing UV exposure doses. Water contact angle
measurements were performed on both the incident and opposing sides of the modified
PMMA to determine water contact angles. Pristine PMMA has a water contact angle of
85º and depending on the UV dose the water contact angle can be significantly
decreased indicating the formation of a hydrophilic surface.25 We observed no change
in the hydrophilicity of the opposing side of the planar PMMA indicating that the surface
modification was limited to the incident side of the exposed PMMA (see Figure 2.2).
2.2.4 Derivatization of UV-modified PMMA and PC. UV-exposed PMMA and PC
surfaces were derivatized with a diamine crosslinking agent followed by covalent
attachment of an amine-selective dye to determine the presence and identity of
functional groups using the procedure described herein (see Scheme 2.1).25
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Scheme 2.1 Modification protocol of PMMA and PC surfaces. The material was first
exposed to UV radiation through a photomask. The groups formed as a result of
exposure were derivatized with ethylene diamine in the presence of EDAC. Any
surface-bound primary amines were subsequently reacted with FITC to produce
fluorescence. F = fluorescein.
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Precut pieces of 0.5-mm-thick PC (Goodfellow) and PMMA (AIN Plastics) were
sonicated in 2 propanol for 15 min and subsequently rinsed again with 2-propanol, then
dried with high-purity nitrogen. A 500-mesh Ni grid was placed over the PC and PMMA
pieces, then the masked pieces of the polymer sheets were placed 1 cm from the UV
source and subsequently irradiated for 30 min in air.
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Figure 2.2 Plot of water contact angles of the incident and opposing sides of PMMA
taken immediately after modification. The black triangles indicate the water contact
angles of the opposing sides of PMMA which are equal to that of unmodified pristine
PMMA. The blue squares show the moderate reduction in water contact angle resulting
from the incident irradiation. Data points and error bars reflect the average of three
measurements and the associated standard deviation from that average, respectively.
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Upon removal from the UV source, the PC and PMMA pieces were sonicated in
nanopure water for 5 min. The cleaned, exposed pieces were then incubated with
agitation for 11 h in a 5 mM EDAC (1-ethyl-1-(3-dimethylaminopropyl)carbodiimide) with
100 mM phosphate buffer (pH=7.0) containing 5 mM ethylenediamine (Aldrich). The
resulting amine-terminated surfaces were then rinsed with Nanopure water and placed
in a 2 mM FITC (fluorescein isothiocyanate) solution in pH 9.0, 0.1 M borate buffer for 4
h, after which they were rinsed with borate buffer and dried in air. Examination of the
derivatized surfaces was achieved with a Nikon Miphot-FXA microscope with a 20X
fluorescence objective equipped with a 510 nm excitation filter and a 520 nm barrier
filter.
The surface morphology of pristine and UV-modified PMMA and PC surfaces was
interrogated

using

atomic

force

microscopy

(AFM),

(Nanoscope

III,

Digital

Instruments/Veeco Metrology Group, Santa Barbara, CA) in the non-contact (tapping)
mode.
2.2.5 Measurement of the Electroosmotic Flow (EOF). The EOF in assembled
devices was measured using the method described by Zare and co-workers.26 The
procedure involved filling the entire chip with a 20 mM buffer. After filling the chip, one
reservoir was emptied and filled with the same type of buffer but of lower ionic strength
(18 mM). An electric field (150 V/cm) was then applied to the reservoirs containing the
low and high ionic strength buffers and the current was monitored continuously using a
strip-chart recorder (Kipp and Zonen Inc., Bohemia, NY). The time needed for the
current to reach a plateau was measured from the plot and the linear velocity calculated.
Dividing the linear velocity by the electric field strength produced EOF values (cm2/Vs).
The electric field was supplied by a Spellman high-voltage power supply (CZ1000R,
Plainview, NY). The electroosmotic flow measurements were carried out through pH
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values of 4-10 on both pristine and UV-modified PMMA and PC microchips. Three
different buffers were used over the investigated pH range; acetate buffer (pH=4.0,
pH=5.0, and pH=6.0); phosphate buffer (pH=7.0 and pH=8.0); and borate buffer
(pH=9.0 and pH=10.0).
2.2.6 Cell Transport. Observations of cell transport were performed using a Nikon
Optiphot 2 microscope (Nikon, Melville, NY) equipped with a JAI CV 252 monochrome
video camera capable of capturing 30 fps. The images were captured directly to the
hard drive of a Dell Precision 500M workstation via a Pinnacle Systems DV500 video
capture card that was interfaced to a Pinnacle Systems Bluebox (Pinnacle Systems,
Inc., Mountain View, CA). The Bluebox served as a conduit for the video transfer to the
computer. Adobe Premiere 6.0 (Adobe Systems, Inc., San Jose, CA) was used for data
acquisition and subsequent data processing.
The programmable high voltage power supply (PHV) was assembled in-house. The
unit consisted of 4 individual power supplies (Model UR5PN, Matsusada Precision Inc.,
Santa Clara, CA) capable of delivering +5 to -5 kV, ground, and floating potentials. Each
power supply was equipped with an independent Reed relay (Model RR1A07P06, Ross
Engineering Corporation, Campbell, CA) that was used to toggle the polarity, ground,
and floating states of the power supply. The power supply was computer controlled with
a 4 channel 12 bit digital to analog board (Model CYDDA 04P, CyberResearch Inc.,
New Haven, CT) with peripheral component interface (PCI) and software written in
Labview (National Instruments, Austin, TX). All experiments were carried out at room
temperature. Caution! The electrophoresis uses high voltages and special care should
be taken when handling the electrodes.
2.2.7 Backscatter Cell Detection. The detection system used for monitoring cell
transport via backscatter detection has been described in detail previously.27 It
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consisted of a diode laser (LDH 680, PicoQuant, Berlin, Germany) lasing at 680 nm.
The diode head was coupled directly to a single-mode fiber for transporting the light to
the detector head. The collimated laser light was directed by a dichroic mirror (Omega
Optical, Brattleboro, VT), which reflected the laser light when the mirror was positioned
at a 45º angle of incidence. The laser light was then focused into the microdevice
channel using a 40X, 0.65 numerical aperture (Θ= 40.5º) microscope objective (Nikon,
Melville, NY). The scatter signal was collected by this same objective, transmitted
through the dichroic, and focused onto a multimode fiber using an objective of the same
power (1:1 imaging). The multimode fiber carried the resulting signal to the detector. An
interference band-pass filter (710AF30, Omega Optical, Brattleboro, VT) and long-pass
filter (705AELP, Omega Optical, Brattleboro, VT) were used to isolate the appropriate
signal. The scattered signal was then focused by a 20X objective (Nikon) onto a SPAD
(SPCM-200 single-photon avalanche diode, EG&G optoelectronics, Vaudreuiel,
Canada). The output pulses produced from the SPAD were amplified (6954 B5 amplifier,
Phillips Scientific, Ramsey, NJ) and fed into a counting board resident on the PC bus
(PicoQuant SPC 430).
2.3 Results and Discussion
The cell types studied herein varied in size and shape. Baker’s yeast cells
(Saccharomyces cerevisiae) are spherical eukaryotic cells with 5-10 µm diameters.
Escherichia coli are bacteria cells with rod-like shape and dimensions of about 1-2 µm.
These cells posses a net negative charge at physiological pH, which along with its size
determines

its

electrophoretic

mobility.2

This

charge

is

a

result

of

protonation/deprotonation of membrane bound materials. Thus, cell charge can be
controlled by altering the properties of the buffer solution (i.e., pH, ionic strength, salt
composition). It has previously been observed that cells suspended in an isotonic salt
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solution start to move toward a positively charged electrode upon application of an
electric field.28 The speed of the movement (i.e., electrophoretic mobility) was found to
be proportional to the density of charges located on the cell surface.
Figure 2.1B and 2.1C present photomicrographs of E. coli (B) and baker’s yeast
cells (C) in a PMMA microfluidic device. Cell velocities in the present study were
calculated by measuring the time a cell migrated a distance of 80 µm, which was the
field of view for the objective used in these studies. The average velocity was based on
values obtained from 5-7 different cells.
2.3.1 Electroosmotic Flow in Polymeric Devices. The most common mechanism of
pumping in microfluidic devices is electrokinetic, which utilizes the electroosmotic flow of
the solution and the electrophoretic mobility of the material being transported. The linear
velocity at which the material moves is governed by Eq. 2.1;

νapp= (µeof + µep)E

(2.1)

where νapp is the apparent linear velocity (cm/s) and is determined from the sum of the
electroosmotic mobility (µeof) and the material electrophoretic mobility (µep) multiplied by
the field strength (E). Throughout this work, mobilities reported from anode to cathode
are positive, and those from cathode to anode are negative.
By modifying the channel surface, we could control the magnitude and direction of
the EOF, resulting in control of transport rate and direction. A simple way to modify
polymers is through exposure by UV light. UV irradiation causes photo-oxidation of the
surface and leaves the bulk material unmodified.14,17-22 While previous studies14,20-22
utilized UV lasers (excimer) to induce these surface charge density changes during
ablative processes, we used a broadband UV source with moderate photon densities,
which would be expected to minimize any polymer ablation.
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Figure 2.3 Plot of EOF vs. pH for unmodified and UV-modified PMMA and PC. The
electroosmotic flow measurements were carried out through pH values of 4-10. Three
different buffers were used; acetate buffer (pH=4.0, pH=5.0, and pH=6.0); phosphate
buffer (pH=7.0 and pH=8.0); and borate buffer (pH=9.0 and pH=10.0). The low
concentration of buffer was 18 mM and the higher concentration was 20 mM. The field
strength used was 0.15 kV/cm. The EOFs were measured using the chips described in
Figure 2.1. For the UV-modified chips, both the coverplates and substrates were
exposed prior to chip assembly.
The EOF values for pristine and UV-modified polymers as a function of pH are
plotted in Figure 2.3. The EOFs for both PMMA and PC as well as for UV-modified
PMMA and UV-modified PC were positive, indicating solution flow from anode to
cathode and thus, negatively charged walls. For the pristine PMMA microdevice, the
observed EOF was 1.72×10-4 at pH=4 and increased to 3.02×10-4 cm2/Vs at pH=9,
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consistent with our previous data.15,16,29 A much larger EOF was seen for the UVmodified PMMA devices (e.g., 1.88×10-4 at pH=4 and 4.67×10-4 cm2/Vs at pH=9). EOFs
measured in the UV-modified PC microchannel showed higher values than in
unmodified PC as well (e.g., 4.73×10-4 and 3.50×10-4 cm2/Vs at pH=7.0 for UV-modified
and pristine PC, respectively). These results can be explained by the production of
higher negative charge densities on the UV-modified material due to the presence of
ionizable groups with lower pKa values than the terminal phenolic groups found in
pristine PC.18,14,21,22 The first derivative of the plots of EOF vs. pH for both UV-modified
PMMA and PC revealed an apparent surface pKa value of 4.2 for UV-modified PMMA
and 4.3 for UV-modified PC. Based on these results, we can speculate that carboxylate
groups are present on both the UV-modified PMMA and PC, since typical literature
values of pKa for alkyl or aryl carboxylic acids are in the range of 4-5.
In order to determine the identity of these charged groups on the surface of PMMA
and PC exposed to low intensity broadband UV illumination, both PC and PMMA sheets
were subjected to UV radiation through a TEM grid and the resulting material reacted
with a diamine in the presence of EDAC, which selectively labels carboxylate groups to
create an amine-terminated scaffold that could be subsequently reacted with FITC.
Following derivatization, the material was imaged using a fluorescence microscope. The
resulting images (brightfield and fluorescent) are shown in Figure 2.4. From these
images, it can clearly be seen that only those areas exposed to the UV radiation
through the TEM grid produced substantial amounts of fluorescence. Since EDAC
coupling of the diamine to the surface is a good indicator of the presence of carboxylate
groups, it can assumed that UV exposure induced a photo-oxidation reaction, similar to
that observed by Locascio and co-workers for laser ablated polymer surfaces.14 A
brightfield image of the PC surface, which can provide information on surface
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morphology, showed no distinct features following UV exposure, indicative of no
significant amounts of surface ablation induced by this dose.

Figure 2.4 Brightfield A, C) and fluorescence B, D) images of PC A, B) and PMMA C,
D) surfaces exposed to broadband UV radiation through a TEM grid and subsequently
reacted with ethylene diamine in the presence of EDAC. Prior to fluorescence imaging,
the functional amine scaffold was reacted with FITC. The fluorescence images were
acquired using 510 nm excitation with the emission monitored at ~520 nm. The PMMA
and PC sheets were exposed to broadband UV radiation (15 mW/cm2) for 35 min.
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However, in the case of PMMA, evidence of slight morphological changes were
apparent following UV exposure as indicated by the presence of features defined by the
TEM grid. However, in the case of PMMA, evidence of slight morphological changes
were apparent following UV exposure as indicated by the presence of features defined
by the TEM grid. AFM images of this surface (see Figure 2.5) indicated a trough depth
of approximately 75 nm.
2.3.2 Cell Transport in Pristine PMMA and PC. Figures 2.6A and 2.6B shows the
linear velocity dependence upon the applied field for baker’s yeast cells in PC (A) and
PMMA (B) with 0.5, 1.0, and 20 mM PBS at pH=7.4. The negatively charged cells would
be expected to migrate in the direction of the anode due to electrophoretic effects,
however, at each buffer concentration in both PC and PMMA baker’s yeast cells
migrated toward the cathode (same direction as EOF).
Clearly, the mobility of these cells is smaller than the EOF resulting in net flow toward
the cathode. It was also observed that the flow velocity of baker’s yeast cells in these
polymer devices decreased with increasing buffer concentration. It is well known that
increasing the concentration of the electrolyte will decrease the EOF due to
compression of the double layer.30 Because the apparent mobility is dependent on the
EOF, decreases in the EOF result in lower mobilities when the apparent mobility is in
the same direction as the EOF, as observed here.
Plots of linear velocity versus electric field were used to extract the apparent
mobilities (µapp) for both types of cells. Table 1 shows a summary of the estimated µapp
for both Escherichia coli and baker’s yeast (Saccharomyces cerevisiae) for pristine
polymers in PBS at pH=7.4. The µapp of

the yeast cells in PC were +2.84x10-4,

+1.87x10-4, and +0.70x10-4 cm2/Vs in 0.5, 1.0, and 20 mM PBS, respectively, where the
positive sign indicates migration in the same direction as the EOF.
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Figure 2.5 AFM images of PMMA following exposure to broadband UV radiation. See
Materials and Methods section for experimental details.
The µapp of these cells in PMMA were lower compared to PC due to the lower EOF in
PMMA but still migrated toward the cathode.12,16,29 Figures 2.6C and 2.6D show the flow
velocity dependence on the applied potential for E. coli cells in PC (C) in 0.5, 1.0, and
20 mM PBS and PMMA (D) in 0.5 and 1.0 mM PBS at pH=7.4. E. coli cells show
opposite behavior to that observed for baker’s yeast in both polymeric materials with 0.5
mM and 1 mM PBS (pH=7.4).
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Figure 2.6 Flow velocity versus applied field strength for baker’s yeast cells on PC (A)
and PMMA (B) microdevices, and E. coli cells on PC (C) and PMMA (D) microdevices.
Channel dimensions the same as stated in Figure 2.1. All velocities were obtained in
PBS buffer (pH = 7.4) at concentrations of 0.5, 1.0, and 20.0 mM.
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At these conditions, the electrophoretic mobility of E. coli cells was greater than the
EOF and resulted in migration toward the anode. Interestingly, in 20 mM PBS the
direction of cell movement in PC (as well as in UV-modified PC and UV-modified
PMMA) was reversed, and the cells migrated in the direction of the cathode. In pristine
PMMA at 20 mM PBS, mixed mobilities were observed; some cells moved toward the
cathode and some in the direction of the anode. Clearly, there is some additional factor
that governs or influences the transport of E. coli in 20 mM PBS. One would expect that
since the EOF would be reduced at higher ionic strength compared to 0.5 and 1.0 mM
PBS the cell apparent mobility would decrease if its µapp was positive.

Table 2.1 Values of apparent electrophoretic mobility (µapp) for E. coli and baker’s yeast
(S. cerevisiae) cells in pristine and UV-modified polymers with phosphate buffer saline
(PBS) pH=7.4.

Cell type

PBS
pH=7.4

µapp in PMMA

µapp in PC

µapp in UVPMMA

µapp in UVPC

x 104 cm2 V-1 s-1

S.
cerevisiae

E. Coli

(+)
4.83±0.80
(+)
2.53±0.21
(+)
0.92±0.04

0.5 mM

(+) 2.57±0.11

(+) 2.84±0.12

(+) 3.64±0.05

1.0 mM

(+) 1.62±0.06

(+) 1.87±0.10

(+) 1.96±0.16

20 mM

(+) 0.66±0.07

(+) 0.70±0.02

(+) 0.71±0.02

0.5 mM

(-) 0.84±0.04

(-) 0.53±0.05

(-) 0.80±0.06

(-) 0.56
±0.10

1 mM

(-) 1.04±0.01

(-) 0.66±0.05

(-) 0.88±0.04

(-) 0.76±0.10

20 mM

mixed flow
directions

(+) 0.16±0.01

(+) 0.14±0.04

(+)
0.28±0.01

Note: (+) mobility indicates flow toward cathode, and (-) mobility indicates flow toward
anode.
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The electrophoretic behavior (i.e., electrophoretic mobility) of cells is mainly controlled
by pH and ionic strength of the medium. Both the degree of dissociation of the
functional groups on the cell surface and the thickness of the double layer surrounding a
cell are determined by the medium pH and ionic strength, respectively, which can
change the electrophoretic mobility.31 For a rigid colloidal particle with a constant
surface potential, Smoluchowski theory predicts that electrophoretic mobility of particles
will decrease proportionally to the square root of the increase in ionic strength.32 This
model, however, may not be applicable in the present case since biological cells are
considered to be non-rigid.33-38 Ohshima and co-workers pointed out that the
electrokinetic behavior of microbes with extracellular polymer layers (i.e., “soft”
particles) will be different from that of rigid particles.33,35 Levine et. al. found that the
electrophoretic mobility of red blood cells is smaller than that calculated according to the
Smoluchowski equation.34 Recently, the electrophoretic mobility of a biological cell was
studied by Hsu et al.36 The authors investigated the effect of pH and ionic strength of
the medium on the electrophoretic mobility of the cell. They concluded that for “soft”
particles, the electrophoretic mobility decreases with an increase in ionic strength due to
a thinner double layer surrounding the cell and the stronger shielding effect of counterions.36
Results for E. coli cells suggest that at low ionic strength (i.e., 0.5 and 1.0 mM PBS)
the electrophoretic mobility was greater than the EOF and resulted in migration toward
the anode. At high ionic strength cell electrophoretic mobility decreased faster than the
EOF in PC resulting in cell migration toward the cathode. In pristine PMMA with 20 mM
PBS, the EOF is suppressed by high buffer concentrations causing some cells to
migrate with the EOF and others against it due to differences in individual cell’s
electrophoretic mobility giving rise to mixed mobility directions.
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2.3.3 Cell Transport in UV-Modified PMMA and PC. In both UV-modified polymers,
baker’s yeast cells moved toward the cathode. The µapp of baker’s yeast cells decreased
with increasing buffer concentration consistent with a lower EOF at higher ionic strength.
The apparent mobility of baker’s yeast in UV-modified PC was +4.83x10-4, +2.53x10-4,
and +0.92 x10-4 cm2/Vs in 0.5, 1.0, and 20 mM PBS, respectively. These µapp are higher
than those obtained in unmodified PC, consistent with a larger EOF for mobilities that
are electroosmotically dominated. The µapp of baker’s yeast cells in UV-modified PMMA
was higher than those in pristine PMMA.
The µapp for E. coli cells in UV-modified PC was found to be -0.56x10-4, -0.76x10-4,
and +0.28 x10-4 cm2/Vs in 0.5, 1.0, and 20 mM PBS, respectively. As can be seen, the
sign of µapp indicates cell travel toward the anode, opposite to the EOF, except with the
highest ionic strength buffer where the cells migrated toward the cathode, similar to
what was observed in unmodified PC. In the case of UV-modified PMMA, the µapp of
these cells was -0.80x10-4, -0.88x10-4, and +0.14x10-4 cm2/Vs in 0.5, 1.0, and 20 mM
PBS, respectively. The µapp of E. coli migrating in UV-modified PMMA was lower than in
unmodified PMMA. For example, in 1 mM PBS at pH=7.4 µapp was -0.88x10-4and -1.04
x10-4 cm2/Vs in UV-PMMA and PMMA microchannels, respectively.
It was found that the EOF in both pristine and UV-modified polymeric devices
showed an increase in magnitude at higher pH values (see Figure 2.3). We therefore
tested the behavior of the cell mobility in microfluidic channels of different buffer pHs in
1 mM PBS. It was observed that the µapp of baker’s yeast increased with increasing pH.
For example, in PC with 1 mM PBS µapp were +1.05(±0.10)x10-4, +2.25(±0.20)x10-4, and
+2.40(±0.40)x10-4 cm2/Vs; and for UV-PC they were +1.15(±0.20)x10-4, +2.65(±0.40)
x10-4, and +2.80(±0.4)x10-4 cm2/Vs, at pH 3, 7.4, and 9.5, respectively. The µapp
increased for both pristine and UV-modified PC with increases in pH, consistent with
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larger EOF values at higher pHs. However, the extent of the increase was more
significant for UV-modified PC due to its larger increase in EOF at higher pH values
compared to pristine PC. Similar trends were also observed for PMMA and UV-PMMA.
The EOF in glass has a magnitude that is typically greater than the electrophoretic
mobility of most analytes or cells. Thus all materials, irrespective of charge, tend to
migrate toward the cathode. The µapp measured in 200 mM PBS (pH=7.4) in glass by Li
et al.2 for baker’s yeast cells was +3.50(±0.57)x10-4 and +2.00(±0.36)x10-4 cm2/Vs for E.
coli. In glass, both types of cells migrated with the EOF. For the polymers investigated
herein, only baker’s yeast cells (regardless of polymer or the buffer ionic strength)
migrated with the EOF. The largest µapp of baker’s yeast cells in polymer microdevices
was observed for UV-modified PC in 0.5 mM PBS (see Table 1). We have found that
the largest µapp for E. coli cells was observed in PMMA in 1 mM PBS (see Table 1). The
largest µapp for cells moving with the EOF was observed in UV-modified PC in 20 mM
PBS (+0.28 x10-4 cm2/Vs). This value is an order of magnitude lower than that observed
in glass.2
Chip-to-chip reproducibility of the measured EOFs and cell flow velocities varied
slightly, however, the direction of the cell transport was reproducible from chip-to-chip.
For example, in 3 different PMMA microdevices, RSD values for the velocities were
approximately 10-12% for both types of cells. For a single microdevice, the RSDs for
flow velocities were usually 5-10% with up to 20% at high applied fields. It was found
generally that the RSD for E. coli cells were higher than those for baker’s yeast. Similar
values for the relative standard deviations have been observed for glass chips
(RSD=10-18%).2
2.3.4 Cell Adsorption. Cell adhesion and adsorption in a microfluidic device can lead to
flow problems mainly due to clogging of the device. Bare silicon and glass surfaces are
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particularly prone to cell adhesion, promoting biofouling under both static and flow
conditions.28 Such problems are especially pronounced when high cell counts are
used.2 The hydrophilic nature of the glass surface makes them unsuitable in many
cases for cell assays without modification. Cell adhesion has been shown to be reduced
by modification of the glass channel walls with trichlorohexadecylsilane,2 or
poly(dimethylacrylamide).39,40 Covalent and non-covalent modification of the channel
surfaces

has

been

performed

with

silane

coupling

agents,

such

as

octadecyltrimethoxysilane (ODTMS),28,39 N-(triethoxysilylpropyl)-O-polyethylene oxide
urethane (TESP),28 and (tridecafluoro-1,1,2,2-tetrahydrooctyl)-1-dimethylchlorosilane
(F13) to minimize cell adsorption.39 The TESP coating was effective at inhibiting glial
cell biofouling, allowing the device to operate for several minutes without failure. The
ODTMS coatings, on the other hand, promoted glial cell adhesion leading to restricted
flow within a few minutes.28 In studies with E. coli cells, ODTMS and F13 were found to
be too hydrophobic for use with aqueous solutions.39
Unmodified PMMA and PC possess more hydrophobic surfaces compared to
glass.16 UV-radiation of these polymers modifies the surface making them more
hydrophilic and potentially more susceptible to cell adhesion.2,39 Indeed, we noticed
minimal cell adhesion/adsorption to the channel wall, channel bottom or coverplate for
the unmodified materials. Even after 1 hr of operation, the channels in unmodified
polymeric microdevices remained unclogged and functional. Although the clogging of
the channels in UV-modified polymers was also not experienced after 1 hr of operation,
it was observed that more yeast cells adhered to these channel surfaces. It was noticed
during microdevice operation that some of the immobilized/adsorbed cells could be
removed by applying higher fields. This was partially caused by an increase in the
number of collisions between flowing and stagnant cells as well as stronger fields that
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were able to “lift” cells from the polymer surface, suggesting that the adhesion forces of
the cell to the polymer surface (UV-modified) were not strong enough to withstand drag
forces produced by the EOF.
2.3.5 Cell Sorting. Figures 2.7A and 2.7B show light scattering signals generated for
two separate suspensions of unlabeled baker’s yeast cells (A) and E. coli (B) in 1 mM
PBS (pH=7.4) using a PMMA microchip. Cells were driven separately using
electrophoretic/electroosmotic forces in the device with a field strength of 0.2 kV/cm. E.
coli cells migrated toward the anode and baker’s yeast cells toward the cathode. Each
scatter signal most likely represents passing of a single cell through the laser beam.
Histograms built for each run are presented in Figure 2.7C. It is evident that the
scattering signal for baker’s yeast cells is larger than that for E. coli. The average signal
was 1,350±432 and 268±86 cps for baker’s yeast and E. coli, respectively. The
observed difference in the magnitude of the scatter signal is mainly due to differences in
size of these two types of cells, but may also reflect shape or surface roughness
differences.6,7,39,41-43
The observed differential cell migration behaviors in polymeric devices suggested
the possibility of presorting these two types of cells electrophoretically. Nano-particles
and biological cells have been shown to be sorted on the basis of their dielectric
properties.44 Sorting was based on the fact that when particles are placed in an AC
electric field, polarized particles experience a variable translational force, which
depends on the applied frequency. Since the polarization is frequency dependent, the
net force is also dependent on frequency. Thus, by manipulation of the medium
conductivity and applied frequency one can separate the particles based on their
dielectric properties.44
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Figure 2.7 Light scattering signals generated for a suspension of unlabeled baker’s
yeast cells (A) and E. coli cells (B) in 1 mM PBS, pH=7.4 in a PMMA microchip. The two
types of cells were run separately. Also shown in (C) are histograms of frequency
versus scattering signal intensity obtained from baker’s yeast and E. coli cells
constructed from the data in (A) and (B). Scattering data were generated with the 680
nm laser at a power of 0.25 mW with a sampling time of 0.5 s. The cells were
electrophoretically/electroosmotically driven at 0.2 kV/cm using the chip described in
Figure 2.1.
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Figure 2.8 Light scattering signals generated for a suspension of an unlabeled mixture
of baker’s yeast and E. coli cells in PBS (pH=7.4) in a PMMA microchip. A) The anodic
reservoir was filled with baker’s yeast and E. coli cell suspensions prepared in 20 mM
PBS, B) the anodic reservoir was filled with baker’s yeast and E. coli cell suspensions
prepared in 1 mM PBS, and C) the cathodic reservoir was filled with both cell types in 1
mM PBS (pH=7.4). See Figure 2.7 for experimental details.
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We present a simple method of sorting two types of cells based solely on their
electrophoretic mobilities. By judicious choice of; (i) the buffer concentration in which the
cell suspension is prepared and; (ii) the polymer material and preparation, we can
selectively introduce a certain cell type into a microfluidic device from a mixed
population of cells. Figures 2.8A-C show scatter data collected for a mixture of
electrically driven baker’s yeast and E. coli cells in an unmodified PMMA microchannel.
In Figure 2.8A, the anodic reservoir was filled with both baker’s yeast and E. coli cells
suspended in 20 mM PBS. At these conditions, the scattering signal was collected for
both baker’s yeast and E. coli cells, since both types of cells enter the microchannel.
When the anodic reservoir was filled with the mixed cell population (baker’s yeast and E.
coli) and suspended in 1 mM PBS (pH=7.4), only high intensity signals were observed
(Figure 2.8B). The observed scattering signal ranged from 1,500 to 4,000 cps,
suggesting that the scatter signal was produced predominately from baker’s yeast cells
(see Figure 2.7C). As expected, at these conditions we were able to presort E. coli cells
from baker’s yeast cells based on their differential mobilities. Figure 2.8C shows data
obtained in a similar experiment as in Figure 2.8B with the exception that the cathodic
reservoir was filled with the mixed population of cells in 1 mM PBS. The scatter signal
with low intensity peaks indicated that only E. coli cells entered the microdevice (see
Figure 2.7C).
2.4 Conclusions
The use of plastics can increase the utility and diversity of devices due to differences
in their surface chemistry and the fact that simple modification chemistries can be
imposed on the material to affect changes in its EOF properties. Electrokinetic transport
of Escherichia coli and Saccharomyces cerevisiae (baker’s yeast) cells was evaluated
in microdevices fabricated in pristine and UV-modified PMMA and PC. The cell
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velocities ranged between a few µm/s to several mm/s. For example, the largest flow
velocity for baker’s yeast cells in these microdevices was observed for UV-modified PC
with 0.5 mM PBS, and the lowest was measured in PMMA with 20 mM PBS. Baker’s
yeast cells migrated with the EOF because their electrophoretic mobility was smaller
than the EOF. The largest flow velocity for E. coli cells was observed in PMMA with 1
mM PBS and the lowest in UV-modified PC with 0.5 mM PBS. E. coli cells migrated
toward the cathode only when the cell suspension was prepared in 20 mM PBS. Our
results demonstrated the feasibility of manipulating the electroosmotic flow by changing
the ionic strength of the buffer and/or modifying the polymer material through UV
exposure, which allowed cell sorting electrokinetically. Therefore, selective introduction
of only one type of cell into a microdevice device from a mixed population could be
performed.
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Chapter 3 Highly Efficient Circulating Tumor Cell Isolation from Whole Blood and
Label-free Enumeration Using Polymer-Based Microfluidics with an Integrated
Conductivity Sensor*
3.1 Introduction
It is generally accepted that most cancer-related mortalities result from metastatic
disease.1 While the process of metastasis is not well understood, a number of chemical,
physical and molecular events occur that ultimately result in the dissemination and
deposition of tumor cells into targeted organs using the circulatory system and/or bone
marrow as the carrier(s). This “seed and soil” process was proposed as early as 1889
by Paget2 and was later modified with the caveat that shed tumor cells consist of a
heterogeneous population with sub-populations possessing different metastatic
potentials.3 The fundamental entities primarily responsible for spawning metastatic
disease are circulating tumor cells (CTCs), which can be produced during early stages
of tumorigenesis.4 Elucidating the quantity of CTCs in peripheral blood or bone marrow
can serve as an indicator for the clinical management of several cancer-related
diseases by providing information on the success/failure of therapeutic intervention and
disease stage forecasting.5,6
The isolation and enumeration of exfoliated CTCs in peripheral blood or bone
marrow for a variety of cancer-related diseases has already been reported, such as
breast,7-9 colorectal,10 prostate,11 renal,12 bladder,13 and non-small cell lung14 cancers.
As an example of the clinical utility of CTC information, Cristofanilli et al. recently
reported a study of 177 breast cancer patients using the amount of CTCs in peripheral
blood as an indicator of survival.7 Patients with ≥5 CTCs per 7.5 mL of whole blood
possessed a median progression-free survival of 2.7 months versus 7.0 months for
those patients containing <5 CTCs in 7.5 mL of their peripheral blood.

*Reprinted with permission from JACS.
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The major issue with securing viable clinical information via quantification of CTC
levels is the extremely low abundance or rare-event nature of these cells amongst a
high number of spectator cells in peripheral blood.6,15-18 For example, it is clinically
useful to quantitatively enumerate 0-10 CTCs in whole blood composed of >109
erythrocytes and >106 leukocytes per mL.7
For sampling rare events in a large population, three important metrics must be
assessed: (1) throughput, the number of cell identification or sorting steps per unit time;
(2) recovery, an indicator of the fraction of target cells collected from the input sample;
and (3) purity, which depends on the number of “interfering” cells excluded from the
analysis.19

In addition to these three metrics, highly efficient quantification of the

number of enriched cells must be provided as well.
The approaches used to date to enrich CTCs from clinical samples have either
provided lower-than-desired recoveries with high purity, relatively poor purity but with
high recoveries, or in other cases, highly specialized sample processing and handling
whose success is laboratory dependent.20-25

For example, immunomagnetic

approaches for CTC enrichment using ferromagnetic micrometer-sized particles coated
with molecular recognition elements specific for antigenic-bearing target cells can
interrogate diluted blood samples typically yield modest recoveries (~70%) but
extremely favorable purity.22 In the case of size-based separations employing nuclear
tracked membranes, polycarbonate membranes with varying pore sizes (8 – 14 µm) can
filter large volumes (9.0 – 18 mL) of blood and recover nearly 85% of the CTCs, but
significant numbers of leukocytes are also retained (i.e., low purity) potentially
complicating the enumeration process.26 Investigations utilizing reverse-transcription
PCR, in which mRNAs are used as surrogates to report CTC levels, have the ability to
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detect one CTC in an excess of 106 mononucleated cells.27 However, these assays are
prone to high inter-laboratory variability and require extensive sample handling and
manipulation.
Most of the CTC isolation/sorting tools currently in use possess some common
procedural characteristics that make them prohibitively difficult to implement, such as
the ability to sort only the mononucleated fraction of whole blood requiring density
gradient centrifugation prior to enrichment and the use of either flow cytometry or
fluorescence microscopy following cell staining to enumerate the number of enriched
CTCs. These additional steps require sample handling and transfer, which can induce
cell loss or contamination that can dramatically affect the assay result, especially when
dealing with low numbers of targets.
Microfluidics provides a venue for producing integrated systems that can process
clinical samples in closed architectures to minimize sample contamination and loss.
However, high throughput sampling of relatively large volumes (>1 mL) has not been a
mainstay for microfluidics due to the macro-to-micro dilemma resulting from the small
dimensional features associated with these devices. For example, exhaustively
sampling a 1.0 mL volume input using a microchannel of 30 µm × 30 µm at a linear
velocity of 1.0 mm s-1 would require 309 h (12.9 days). This sampling bottleneck was
recently addressed by studies with a glass-based microfluidic fabricated using deep
reactive ion etching.28 The high-surface area immunological capture bed consisted of
microposts (100 µm diameter x 100 µm tall) arranged in an equilateral triangular format;
the device was capable of capturing ~60% of CTCs from untreated whole blood with
enumeration achieved by cell staining and microscopic visualization.
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Herein we report our efforts aimed toward the development of a self-contained
system capable of meticulously separating intact CTCs from peripheral blood and
directly quantifying the CTC level upon isolation and enrichment. As a result of careful
fluidic design rules and system integration methods, we have successfully employed a
microfluidic system capable of exhaustively and rapidly interrogating >1.0 mL of
unprocessed whole blood possibly harboring low-abundant CTCs. At the heart of the
system were carefully engineered, exceedingly efficient high-aspect ratio capture beds
decorated with mABs specific for antigenic integral membrane proteins expressed in
CTCs of epithelial origin and a label-free, highly specific single-cell conductivity sensor.
The device operational characteristics were achieved by tailoring the dominant CTC
capture dynamics, specific device architecture and suspension linear velocity in a high
throughput microsampling unit (HTMSU) containing high-aspect ratio microstructures
replicated in a polymeric substrate. Direct single-cell counting of the captured cells was
made possible by their release as a result of enzymatic digestion of cellantigen/antibody-surface complexes. Quantitative assessment of CTC numbers was
accomplished using an integrated conductivity sensor capable of specifically detecting
CTCs via their electrical signatures without requiring cell staining or microscopic
visualization.
3.2 Material and Methods
3.2.1 HTMSU Fabrication. Figure 3.1 shows a schematic of the HTMSU and several
micrographs of this polymer-based device. The device consisted of a series of 51 highaspect ratio channels that were either linear or sinusoidally configured and shared a set
of common input/output ports. Devices were replicated from a mold master using hot
embossing.
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Figure 3.1 Schematics of the HTMSU showing: (A) A scaled AutoCAD diagram of the
sinusoidally-shaped capture channels (mould insert feature height: red is 150 μm, green
is 80 μm, and orange transitions from 80 to 150 μm over a 2.5 mm length) with
brightfield optical micrographs of; (B) the integrated conductivity sensor consisting of
cylindrical Pt electrodes that were 76 µm in diameter with a 50 µm gap; (C) single port
exit where the HTMSU tapers from 100 µm wide to 50 µm while the depth tapers from
150 µm to 80 µm over a 2.5 mm region that ends 2.5 mm from the Pt electrodes; (D)
micrograph taken at 5x magnification showing the sinusoidal cell capture channels; and
(E) 3D projection of the topology of the HTMSU obtained at 2.5 µm resolution using
non-contact optical profilometry (arrows indicate the platinum electrode conduits).
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See the Chapter 4 for details on the fabrication of the mold master and the microreplication. The substrate selected for the HTMSU was PMMA due to its high fidelity of
forming structures with high-aspect ratios via micro-replication, minimal non-specific
adsorption of whole blood components to its surface and its ability to generate
functional surface-scaffolds through UV irradiation for the attachment of a variety of
biological moieties.29 The HTMSU was manufactured via micro-replication from a metal
master. Microstructures were milled onto the surface of a brass plate with a highprecision micromilling machine (KERN MMP 2522, KERN Micro- und Feinwerktechnik
GmbH & Co.KG; Germany) following our previously published procedures.30

The

micromilling machine was fitted with a laser measuring system (LaserControl NT, BlumNovotest GmbH, Germany) for automatic determination of tool length and radius, and
an optical microscope (Zoom 6000, Navitar, Inc. Rochester, NY) for monitoring the
milling process. Micromilling was carried out at 40,000 rpm. Feed rates were dependent
on the size of the milling tool and were typically in the range of 200 mm/min for a 500
µm milling bit, 100 – 150 mm/min for the 200 µm bit, 50 – 75 mm/min for the 100 µm bit
and 10-20 mm/min for a 50 µm bit. A typical milling cycle consisted of a pre-cut of the
entire surface with a 500 µm milling bit to ensure parallelism between both faces of the
brass plate and uniform height of the final milled microstructures over the entire pattern,
a rough milling of the microstructures using either a 500 or 200 µm milling bit, and a
finishing cut with a smaller diameter milling bit. In the final step of mold master
fabrication, burrs were removed by mechanical polishing. Polishing was performed by
hand on a 3 µm grain-size polishing paper (Fibrmet Discs - PSA, Buehler, Lake Bluff, IL)
followed by polishing on a polypropylene cloth (Engis, Wheeling, IL) with a 1 µm
diamond suspension (Metadi Diamond Suspension, Buehler).
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Three identical HTMSUs were patterned onto the master enabling production of the
units in triplicate during each hot embossing step. In order to accommodate the Pt
electrodes used for the conductivity sensor and the inlet/outlet capillaries, the HTMSU
was designed with multilevel features.30 The depth of the HTMSU detection zone was
tapered to 80 µm from the 150 µm used in the cell selection beds and throughout the
inlet region. The detection channel width was tapered from 100 µm to 50 µm over a 2.5
mm region beginning at the converged outlet and terminating 2.5 mm from the
conductivity electrodes scaled for specific detection of CTCs. In the cell selection bed,
channel widths (35 μm) that closely matched the average target cell diameter were used
to increase the probability of cell-immobilized antibody encounters. To reduce the
pressure drops when the device was operated at high volumetric flow rates, the HTMSU
was designed with deep (150 μm), high-aspect ratio channels.
Prior to embossing and assembly, PMMA substrates and cover plates were cleaned
with reagent grade isopropyl alcohol, IPA (Sigma-Aldrich, St. Louis, MO), rinsed with 18
MΩ

nanopure

H2O

obtained

from

a

water

purification

system

(D8991,

Barnstead/Thermolyne, Dubuque, IA), sonicated for 30 min, rinsed with IPA again and
air dried. Hot embossing was performed with a Jenoptik Microtechnik HEX02 (Jena,
Germany). For embossing PMMA, the substrate was heated to 140°C and a pressure of
20 kN was applied for 630 s. After the HTMSUs were hot embossed, they were cooled
to room temperature and cleaned with IPA.
Regio-specific ultraviolet (UV) modification of the PMMA substrate and cover plate
was performed through an aluminum photomask to facilitate the formation of the
carboxylated scaffold for directed antibody tethering exclusively within the cell selection
beds of the HTMSU. Before final assembly via thermal fusion bonding, the PMMA cover
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plate and substrate were locally irradiated at 254 nm with 15 mW cm-2 fluence for 10
min using a UV exposure station (ABM, Inc., San Jose, CA). Additionally, into the
inlet/outlet ports of the device were inserted 237 μm OD and 150 μm ID polyimidecoated fused silica capillaries and the Pt electrodes fabricated with the required gap
(see Materials and Methods). After thermally annealing the cover plate to the substrate,
a thin film of epoxy resin was applied to the capillary-device interfaces to prevent leaks.

Scheme 3.1 Directed antibody tethering through EDC/NHS coupling. A UV-modified
PMMA surface is exposed to a solution containing both EDC and NHS which forms a
stable succinimidyl ester that is subsequently reacted with an amine containing antibody
ultimately forming a covalent amide bond.
Following UV modification of PMMA, the physicochemical properties of the surface were
effectively altered resulting in a moderate reduction of the glass transition temperature
(Tg) at the cover plate-substrate interface. The resulting Tg allowed for efficient thermal
fusion bonding at 101°C rather than the 106°C Tg of pristine PMMA31,32, which could
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reduce potential thermal deformation of the high-aspect ratio microfeatures. Thermal
fusion bonding was carried out in a gas chromatographic (GC) oven (Varian 3400, Palo
Alto, CA) using the PMMA cover plate and the open-faced, hot embossed PMMA
substrate. The substrate and cover plate were aligned and clamped together between
two borosilicate glass plates and the assembly placed into the temperature
programmable oven of the GC, where the temperature was increased from 50°C to
101°C at a rate of 20°C/min. The temperature was held at 101°C for 15 min.
3.2.2 Antibody Immobilization. Antibody immobilization was performed using a two
step process. Initially, the UV-modified HTMSU device, following thermal assembly, was
loaded with a solution containing 4.0 mg/mL of 1-ethyl-3-[3-dimethylaminopropyl]
carbodiimide hydrochloride (EDC), 6.0 mg/mL of N-hydroxysuccinimide (NHS) in 150
mM 2-(4-morpholino)-ethane sulfonic acid at pH = 6 (MES, Fisher Biotech, Fair Lawn,
NJ) and buffered saline (Sigma-Aldrich, St. Louis, MO) for 1.0 hr to form the
succinimidyl ester intermediate. The EDC/NHS solution was then hydrodynamically
replaced with a 1.0 mg/mL monoclonal anti-EpCAM antibody (R&D Systems Inc.,
Minneapolis, MN) solution contained in 150 mM PBS at pH = 7.4 (Sigma-Aldrich, St
Louis, MO) and allowed to react for 4 h after which the device was rinsed with a solution
of PBS (pH = 7.4) to remove any non-specifically bound anti-EpCAM antibodies.For a
complete description of this procedure, see the Appendix.
3.2.3 Apparatus. A PHD2000 syringe pump (Harvard Apparatus, Holliston, MA) was
used to hydrodynamically process samples using the HTMSU. In order to interface the
HTMSU to the pump, a luer lock syringe (Hamilton, Reno, NV) was fitted with a luer-tocapillary adapter (InnovaQuartz, Phoenix, AZ). The syringe pump was programmed to
generate the appropriate volume flow rate to evaluate CTC cell capture efficiency and
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post-capture cell retention. The linear velocities were calculated from the crosssectional area of the respective HTMSU capture channels and the programmed volume
flow rate. The flow rates were validated by tracking, via optical microscopy, suspended
cells over a fixed 80 µm region.
During evaluative experiments, the HTMSU was fixed to a programmable motorized
stage of an Axiovert 200M (Carl Zeiss, Thornwood, NY) microscope, which could
monitor the transport of cells in the HTMSU using either fluorescence or brightfield
imaging. Videos of cell transport were captured at 30 frames per second (fps) using a
monochrome CCD (JAI CV252, San Jose, CA). For fluorescence, excitation was
accomplished using a Xe arc lamp and dye-specific filter sets appropriate for the
fluorescent dye used for labeling the MCF-7 cells (Carl Zeiss, Thornwood, NY). Each
filter cube contained a dichroic mirror, emission filter, and excitation filter.
3.2.4 Integrated Conductivity Sensor. The conductivity electrodes consisted of Pt
wires (~76 µm) placed into guide channels that were embossed into the fluidic network
and positioned orthogonal to the fluidic output channel (see Figure 3.1). A Pt wire was
inserted into these guide channels prior to thermal assembly of the cover plate to the
substrate. Once the wire was positioned, the substrate/wire assembly was placed
between glass plates and clamped together and finally, heated to slightly higher than
the glass transition temperature of PMMA, which embedded the wire into the guide
channels and spanned the entire depth of the output channel. To break through the wire
to form the electrode pair, a high precision micromilling machine (KERN MMP 2522,
KERN Micro- und Feinwerktechnik GmbH & Co.KG; Germany) with a 50 μm bit was
used (see Figure 3.1B). Following machining of the Pt wire and UV activation, the cover
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plate was aligned to the embossed substrate via alignment marks and clamped together
between two glass plates and subjected to thermal fusion bonding.
The conductivity sensor was assembled in-house (for details see Appendix).
Conductivity measurements were conducted in TRIS-glycine buffer containing 0.25%
(w/w) trypsin, 0.18 mM TRIS, 47 mM glycine and 0.05% (v/v) Tween-20, referred to as
the CTC releasing buffer. This CTC releasing buffer was carefully selected in large part
for its relatively low conductivity (~50 µS/cm, pH 7.2) and the addition of trypsin to
remove the bound CTCs from the capture channel surface for enumeration via singlecell conductometric counting.
3.2.5 Cell Suspensions. Citrated whole rabbit blood was purchased from Colorado
Serum Company (Denver, CO). Upon collection, the blood was combined with 10%
(w/w) sodium citrate to prevent coagulation. The MCF-7 cells (breast cancer cell line),
growth media, phosphate buffered saline, trypsin, and fetal bovine serum was
purchased from American Type Culture Collection (Manassas, VA). Adherent MCF-7
cells were cultured to 80% confluence in Dulbecco’s modified Eagle’s Medium
supplemented with high glucose containing 1.5 g L-1 sodium bicarbonate (NaHCO3), 15
mM HEPES buffer, and 10% fetal bovine serum (FBS). A 0.25% trypsin solution was
prepared in 150 mM PBS and used to harvest the MCF-7 cells.
MCF-7 cells were stained with a fluorescein derivative, PKH67, containing a
lipophilic membrane linker for fluorescence visualization experiments (Sigma-Aldrich,
St. Louis, Mo). A modified protocol for cell staining was implemented whereby the dye
concentration was increased 2-fold resulting in more evenly distributed fluorescent
labels over the cell’s membrane. Cell counts for seeding experiments into whole blood
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were determined by counting three aliquots of cells in succession using a
hemacytometer. The cell count accuracy was within 10%.
3.3 Results and Discussion
3.3.1 Model CTC System. The MCF-7 cell line, used as a model for CTC selection and
enumeration via the integrated HTMSU, is a breast cancer cell line that possesses an
over-expressed membrane antigen termed the epithelial cell adhesion molecule,
EpCAM.33-37 MCF-7 cells are typically 15 – 30 µm in diameter (mean = 24 μm) and have
been closely associated with micrometastatic breast cancer.38
frequency of 5.1×105 molecules per cell.38

EpCAM occurs at a

Monoclonal antibodies for EpCAM are

available, which can be used to selectively speciate these cells from mixed populations.
3.3.2 Major Considerations. A number of experimental and device operational
parameters were investigated to optimize the performance of the HTMSU: (1)
Throughput – linear flow velocity, pressure drops, processing time; (2) recovery –
capture channel geometry (shape and width), and cell flow dynamics; (3) purity –
designing surfaces to minimize non-specific adsorption and provide high selectivity for
the target cells.
3.3.3 Pressure Drop. Because the goal of the HTMSU was to process whole blood
directly in a high throughput format requiring high volumetric flow rates to reduce
processing time, we employed capture channels with high-aspect ratios (aspect ratio =
channel height /channel width). For a capture channel width and height similar to the
cell dimensions (aspect ratio = 1), capture of a cell within this channel would produce a
large pressure drop due to blockage and possibly damage the captured cell making it
unavailable for enumeration. Therefore, we adopted a capture channel geometry with
an aspect ratio of 4.3; for a 35 µm channel width, the depth was 150 µm, which could
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easily be replicated using hot embossing. From Equation 4.6 (see Chapter 4), and a
blood viscosity of 4.8 cP (hematocrit = 0.4), the pressure drop for a channel 35 µm x 35
µm (L = 3.5 cm) was calculated to be 7.4 x 103 Pa, while a channel that possessed
dimensions of 35 µm x 150 µm had a pressure drop of 2.9 x 103 Pa, a reduction of
greater than 60%.
3.3.4 Flow Dynamics. It has been observed that laminar flow in a tube (capillary)
having dimensions greater than 15% that of the cells being transported results in a
marginal zone near the tube wall due to migration of the cells toward the central axis of
the tube leaving a cell-free layer adjacent to the wall that can be as thick as 4 μm.39
Because the capture elements (antibodies) are poised on the channel wall, this focusing
effect can reduce the number of encounters between the CTCs and their recognition
elements. To investigate this phenomenon, we imaged CTCs stained with a membranespecific fluorescein derivative as they were transported through an unmodified (no
mAB) 35 µm wide microchannel that had a straight or sinusoidal configuration (see
Figure 3.1). The results of these experiments are given in Figure 3.2; shown in the
panels are the effects of channel shape and cell translational velocity (U) on the cells’
radial position within the microchannel. Evident in the linear channels (Figure 3.2A and
3.2B) is a cell-free zone, similar to what has been observed in straight capillarie,40
whose thickness increased with increases in U. However, for the sinusoidally-shaped
capture channels, CTC flow dynamics were quite different. First, there was no apparent
marginal zone along one edge of the microchannel wall, and secondly, the cell radial
distribution seemed to be unaffected by changes in U. The result would be an increase
in the antigen/antibody encounter rate as the cells moved through the capture beds at
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the relatively high linear velocities required to process large input volumes in reasonable
amounts of time using sinusoidal-shaped channels.
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Figure 3.2 Histograms of the radial position of CTCs (centroid) in microchannels with
Poiseuille flow at linear velocities (U) of 1.0 mm s-1 and 10 mm s-1 in both straight (A, B)
and sinusoidal-configured (C, D) channels. The dashed line represents the
microchannel’s central axis. (A & B) The radial position of several CTCs histogrammed
from micrographs of the straight microchannel with linear flow rates of 1 mm s-1 and 10
mm s-1. (C & D) The radial position of several CTCs traversing ¼ of a period of the
sinusoidal microchannels with suspension linear velocities of 1 mm s-1 and 10 mm s-1.
The cells were imaged using fluorescence microscopy with the cells stained using a
fluorescein lipophilic membrane dye, PKH67.
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3.3.5 Effects of Channel Width and Linear Velocity on Capture Efficiency. In order
to maximize the recovery of CTCs from whole blood, the dimensions and layout
architecture of the capture channels and the linear flow velocity in which to operate the
HTMSU were assessed. Experimental determinations of CTC capture efficiency using
cell selection channel widths of 20, 35, and 50 µm (straight channels) were evaluated as
well as a 35 µm wide capture channel adopting a sinusoidal pattern. The results of
these studies are depicted in Figure 3.3A as plots of CTC capture efficiency (%) versus
linear velocity, U (mm s-1).
The 20 µm wide channel yielded 100% capture efficiency at all flow rates
investigated. Because the CTCs were often larger than this channel, the cell
membranes were in constant proximity to the antibody-coated microchannel walls. Also,
most CTCs when observed via fluorescence microscopy did not enter the capture
channel because their size was larger than the channel width. Those cells that were
able to enter the selection bed, capture occurred within the first 1-2 mm of the 3.5 cm
long channel. Due to these effects, the 20 μm device demonstrated consistent failure
resulting from microchannel blockage. At higher linear flow velocities these blockages
also led to compromising head pressures that resulted in device failure due to cover
plate detachment from the embossed substrate. Therefore, adopting a channel width
less than the cell average diameter was deemed inappropriate due to device failure and
cell selection partly arising from size exclusion effects, which could lead to selection of a
large number of leukocytes potentially complicating the enumeration process.
Inspection of the data in Figure 3.3A for capture channels with widths greater than
the average CTC cell diameter showed that the capture efficiency increased with
increasing linear velocity for all channel widths and shapes until a critical value was
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reached (~2 mm s-1) at which point the capture efficiency decreased. For all capture
channel widths and shapes when operated at the same linear velocity, improved
capture efficiencies were obtained for narrower channels with the highest efficiency
demonstrated for the sinusoidal-shaped 35 µm wide channel (97%).
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Figure 3.3 Data showing the capture efficiency of CTCs as a function of the cells’
translational velocity using 20 (black squares), 35 (red down triangles, sinusoid; purple
circles, straight), and 50 µm (blue up triangles) wide microchannels. (A) The microfluidic
device consisted of a single channel with the appropriate width and a depth of 150 µm.
Following processing of the input buffer containing the MCF-7 cells, the number of
captured cells was determined via brightfield microscopy by interrogating the entire
length of the capturing channel. (B) The capture efficiency data as a function of the CTC
translational velocity was replotted using Equation 4.10 (see Chapter 4) with this data fit
using the fitting parameter, kin (EpCAM:anti-EpCAM forward rate
to
constant). Error bars represent the average 6 % variance in the capture efficiency.
(Continued on next page)
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Figure 3.3B See caption above.
This latter observation was consistent with the focusing effects noted for cells moving in
a small channel experiencing laminar flow (see Figure 3.2).
To understand the capture efficiency dependence on linear velocity, we evaluated
our data according to the Chang and Hammer model for cell adhesion between a
surface-tethered antibody and a moving antigen.41 This model describes a two-state
process;
(3.1)
(3.2)
where the first step (Equation 3.1) accounts for transport of the solution antigen to the
surface-bound antibody, which describes the encounter rate (ko), and the second step
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(Equation 3.2) gives the probability (P) that an association event will occur during the
time the antigen is in close proximity to the tethered antibody. The encounter rate, ko,
increases with increasing linear flow velocity while the probability of a reaction, P,
decreases (see Figure 4.2 in Chapter 4). Analytical expressions for ko and P are
provided in Chapter 4 based on the Chang/Hammer model.41

Below the cell

translational velocity of 2 mm s-1, the capture efficiency is determined primarily by ko,
but at U > 2 mm s-1, the capture rate is dominated by P. Plotted in Figure 3.3B is the cell
adhesion rate, kads (see Equation 4.10 in Chapter 4) versus the cells’ translational
velocity, which shows that kads asymptotically approaches a limiting value at
translational velocities larger than 2 mm s-1. The data plotted in Figure 3.3B were then
fit to the velocity-dependent intrinsic adhesion rate constant, kf, calculated from the
product of ko and P (see Equation 4.7 in the Chapter 4) with one adjustable parameter,
kin, which represents the forward rate constant between EpCAM and its anti-EpCAM
antibody. Literature values for the MCF-7 cell line and the EpCAM:anti-EpCAM complex
were used to calculate P (see Equation 4.9 in Chapter 4 as well as Table 3.1). The best
fit was achieved for kin = 1 x 107 s-1, which is nearly two orders of magnitude larger than
that reported in the literature for the EpCAM:anti-EpCAM forward rate constant (0.99 x
105 s-1).42 This disparity was most likely due to cooperativity effects resulting from the
high expression level of EpCAM in this cell line.43 In addition, the non-deformable nature
of cell adhesion assumed in the Chang/Hammer model was not observed in the current
experiments (see Figure 4.3 in the Chapter 4).
A device with a single 35 x 150 µm channel operating at the optimal linear flow rate
determined above to maximize the capture efficiency would exhaustively process 1 mL
of input in 9.5 x 105 s (26 h). Simple increases in the linear velocity would not improve
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the sampling throughput without sacrificing capture efficiency, so the device was
designed to contain multiple capture channels of similar dimensions fanning from a
common input. For example, with 51 capture channels, the processing time was
reduced to 1.9 × 103 s (31 min). The common output for all of the capture channels
allowed for enumeration of cells selected from each channel (190 nL volume) in one
step.

Figure 3.4 Time lapse micrographs of a captured MCF-7 cell: (A) Prior to exposure to
the CTC releasing buffer; and (B) exposed to the CTC releasing buffer for ~10 min. (C)
The cell appears to be released from the PMMA surface and finally, (D) the cell is swept
away when the flow is initiated.
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3.3.6 Shear Effects on Captured Cells. It was necessary to evaluate shear forces
induced by the fluid traveling through the channels during cell selection and device
washing prior to cell counting used to quantitatively enumerate the number of captured
cells. Flow-induced shear could either detach the captured cells from the antibodydecorated walls or damage the cell prior to counting.
The total adhesion force (FA) between the cell and the antibody-decorated PMMA
wall was evaluated using the model suggested by Bell.44 FA is derived from the product
of the contact area, antibody surface density and the adhesion force for a single
EpCAM:anti-EpCAM bond, fc (see Equation 4.12 in Chapter 4). The value determined
for fc was 6.7 × 10-6 dynes (see Equation 4.14 in Chapter 4) with a contact area of 16.6
µm2 for MCF-7 cells assuming the cells upon adhesion to the surface are nondeformable (see Equation 4.13 in Chapter 4). Using these values and an anti-EpCAM
antibody PMMA surface density of ~2.3 × 1011 cm-2 produced a total adhesion force of
0.26 dynes.45 For cells that are flattened and elongated upon adhesion (see Figure 4.3
in Chapter 4), the contact area was determined to be 456 μm2 and FA = 7.0 dynes

46

.

When the shear force (FS) generated by the laminar flow is equal to or greater than FA,
the cell can be removed from the surface. The velocity dependent shear force, FS, was
determined from Stokes’ law;

6

(3.3)

where r is the cell radius (12 µm for MCF-7 cells), η is the solution viscosity (4.8 cP for
whole blood with a hematocrit level of 0.4) and

is the critical linear velocity that can

induce cell detachment. Rearrangement of Equation 3.3 produced a value of 2.4 x 102
cm s-1 for

assuming non-deformable contact. Insertion of the contact area and FA for

the flattened and elongated captured cells yielded a value for
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of 6.4 x 103 cm s-1.

Both of these values are significantly greater than the linear velocities used in the
present experiments for optimizing the capture efficiency. Several captured cells were
observed continuously during experiments in which linear velocities up to 10.0 cm s-1
were implemented and no cell damage or disruption of cell:wall adhesion was detected.
3.3.7 Detachment of Intact Cells for Quantitative Enumeration. Due to the strong
adhesion force between the captured cells and the antibody-containing capture surface,
thermodynamic release from the surface to allow for cell enumeration using the
conductivity sensor was deemed in appropriate. The use of the proteolytic enzyme,
trypsin, for the release of captured cells without causing cell disassembly, which would
complicate single cell counting, was investigated. Figure 3.4 shows time-lapse
micrographs of a surface-captured cell that was subjected to trypsin processing.
Detachment was facilitated by the proteolytic enzyme in less than a 10 min incubation
time. Rigorous evaluation of the trypsin release procedure indicated no cell damage
was induced by this process.
3.3.8 Conductivity Sensor for Cell Enumeration. Once the cells were released from
the capture surface, they could be swept through the integrated Pt electrodes at the
device output. The Pt electrodes were separated by 50 µm producing a cell constant, K
(defined as the ratio of electrode gap to the electrode area), of ~0.01 µm-1. The cell
constant was scaled to specifically detect CTCs due to their larger size with respect to
leukocytes or erythrocytes. As shown in Figure 3.5A, the conductivity sensor with K =
0.01 µm-1 did not transduce the presence of leukocytes or erythrocytes due to their
smaller size and their characteristic electrical properties. This is particularly attractive,
because any non-specific adsorption of leukocytes or erythrocytes during cell selection
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will not produce false positive signals providing an additional level of system specificity
for the enumeration of CTCs.
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Figure 3.5 Conductance responses (in arbitrary units, AU) and calibration plots for
CTCs are shown. (A) Conductometric response for suspensions of leukocytes and
erythrocytes (cell density = 150 cells/µL) in TRIS-Glycine buffer transported through the
integrated conductivity sensor at a volume flow rate of 0.05 µL/min. (B) Conductometric
response of a 1.0 mL aliquot of whole blood spiked with 10 ±1 CTCs and processed in
the HTMSU at 2.0 mm/s. The isolated CTCs were released from the PMMA surface
using the CTC releasing buffer and transported through the conductivity sensor at a
volumetric flow rate of 0.05 µL/min. Peak identification was based on a signal-to-noise
threshold of 3:1, which was determined by the peak height of the apparent response
and the average peak-to-peak variation in the conductance of the CTC releasing buffer.
The arrows designate those peaks scored as CTCs based on the aforementioned
criteria. The arrow marked with an “x” possessed a conductivity response lower than the
background buffer and as such was not scored as a CTC. (C) Calibration plot for the
number of CTCs seeded (10 – 250 cells mL-1) into whole blood versus the conductance
responses registered using the conductivity sensor following the processing steps
delineated in Figure 3.5B (m=0.945, r2=0.9988). The data presented in Figure 3.5B was
subjected to a 3 point Savitsky-Golay smooth. (Continued on next page)
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Figure 3.5 (B and C) See caption above.
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Following antibody-mediated capture of CTCs seeded into whole blood using the
HTMSU, the cells were released from the surface and hydrodynamically driven through
the contact conductivity sensor.32 The chemical composition of CTCs make them ideal
candidates for detection using conductivity due to their unique electrical properties
compared to erythrocytes or leukocytes. For example, CTCs in general possess very
low membrane potential and low impedance resulting from the intracellular migration of
sodium ions (Na+) in compensation for the depleted potassium ion concentration (K+) of
the intracellular fluid. Also, alteration in the cancer cell’s membrane content with respect
to the types of glycoproteins and antigens they express result in an increase in the
number of negatively charged sialic acid molecules that cap the extracellular domains of
many integral membrane proteins.47
We next analyzed 1 mL of whole blood seeded with 10 ±1 CTCs using the HTMSU,
released the enriched cells and quantitatively counted them with the conductivity sensor
(see Figure 3.5B). Based on a signal-to-noise threshold of 3 (99.7% confidence level),
there were 8 peaks in the conductance trace shown in Figure 3.5B that were assigned
to CTCs. As can be seen from Figure 3.5B, only positive conductance spikes were
scored as CTCs, while negative spikes were not scored as CTCs. The CTC scoring
system was verified through brightfield microscopy, which indicated that CTCs produced
positive signals relative to the background conductance generated by the CTC releasing
buffer and the negative signals were produced from particulates. In addition, careful
microscopic inspection indicated that the positive conductance spikes were indeed due
to single cells. The disparity in the peak response for single CTCs was due to
differences in cell morphology and composition partly resulting from any one of five
mitosis phases of this cell line upon harvest.48
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For proper enumeration of the recovered CTCs using the HTMSU, the readout
phase of the assay required a sampling efficiency near 100% so that every cell released
from the capture channels could be detected with sufficient signal-to-noise to be scored
as a CTC. To accomplish this and keep the conductivity cell constant (K) at a sufficient
level to provide high signal-to-noise for the CTCs, the HTMSU was designed with a
multi-level architecture (see Figure 3.1E). The 150 µm deep capture channels were
tapered to a depth of ~80 µm at the conductivity sensor to match the Pt electrode
diameter to ensure a sampling efficiency near 100%.
To verify the recovery and detection efficiency of the system, the seed number of CTCs
in whole blood versus the number of cells enumerated over a broad physiologicallyrelevant range (10-250 CTCs mL-1) were evaluated (see Figure 3.5C). The best fit line
to these data indicated a slope of this calibration curve of 0.945 with an intercept near 0
(r2 = 0.9988), indicating near 100% recovery and detection of the CTCs seeded into
these samples using the HTMSU.
3.4 Conclusions
A novel polymer-based HTMSU was designed, fabricated, and tested for selecting,
with high efficiency and specificity, CTCs directly from whole blood using surfaceimmobilized monoclonal antibodies targeted for membrane proteins unique to this class
of cells. Due to the simple and low-cost production of these devices using microreplication technologies as well as their automated operation with no sample preprocessing required, the HTMSU can be envisioned as an important diagnostic tool for
monitoring CTC levels in a variety of adenoma-based cancers for disease detection,
cancer staging or evaluating the effectiveness of therapeutic intervention. A compelling
attribute of this microfluidic device is the ability to specifically detect the CTCs using an
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integrated conductivity sensor. The sensing platform did not respond to potential
interferences, which could give rise to false-positive signals, and was simple to
implement both operationally (no cell staining as required for fluorescence) and
instrumentally (no optical microscope or flow cytometer was required).
The HTMSU was designed to process large input volumes to search for rare events
using molecular recognition via integral membrane proteins specific for the target. High
throughput processing was realized by using a number of high-aspect ratio
microchannels configured in parallel, providing the ability to process 1 mL of input in
~30 min. If the channel depth was increased to 250 – an aspect ratio of 7.14 for 35 μm
wide channels – and the number of parallel channels doubled, the sampling time for this
same volume input could be reduced to 2.7 min. These changes could provide the
ability to select extremely rare events requiring the need for processing larger input
volumes (>10 mL).
The HTMSU is flexible in function as well with the ability to change the molecular
recognition element to target other rare cells. For example, E. coli O157:H7 is a
bacterial species typically found in a variety of fresh water bodies with EPA acceptable
colony forming unit levels of <20 in waste water and <200 in lakes and rivers per 100
mL. Using monoclonal antibodies specific for this bacterium and scaling the capture
channel widths and conductivity sensor appropriate for these cell types, the reported
device can be envisioned for field deployment to provide timely results for assisting in
bacterial containment.
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Chapter 4 Theory, Models, and Expansion of Highly Efficient Circulating Tumor
Cell Isolation from Whole Blood and Label-free Enumeration Using PolymerBased Microfluidics with an Integrated Conductivity Sensor*
4.1 Conductivity Detection Electronics
To measure conductance changes in the CTC releasing buffer of the HTMSU
induced by single CTCs, a specially-designed circuit was developed (see Figure 4.1).
To reduce the effects of parasitic capacitance, Cp, due to wiring and the electrode
configuration, a synthetic inductor, L, of 132 mH was designed using a gyrator circuit.
Gyrators, for a given bandwidth, allow the creation of high Q inductors from RC
components. This inductance was placed in parallel with Cp and the sine frequency
varied to locate the resonance peak of the voltage across L and Cp. Once this
resonance point was found, the voltage across the sample cell was directly sensitive to
changes in Gs (solution conductance). A target frequency of 40 kHz was chosen to
minimize the impedance due to Cd (double layer capacitance) and hold the inductance
to a reasonable value. This signal was fed to a transconductance amplifier, G1, which
converted the voltage sinusoid into a current. The gain of G1 was 10 μA/volt. A current
source was needed to drive the sample cell because a voltage source, with its low
output impedance, would reduce the circuit’s Q. The current was set to ±5 µA for the
experiments. The required resonance frequency (f) could be approximated by the
standard parallel resonance equation;

1

/

2

(4.1)

The voltage across the sample cell was fed to an Analog Devices AD630 synchronous
modulator/demodulator (Norwood, MA) that was configured as a phase sensitive
detector. The reference input of the AD630 was driven from a phase-delayed sine wave
*Reprinted with permission from JACS.
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oscillator output. This phase adjustment was needed to compensate for phase lags in
the detected sample voltage. The sample voltage was fed to a low pass filter with a
cutoff frequency of 180 Hz. The filter produced an average dc signal that was sent to a
differencing amplifier, A1. The difference amplifier served to null the output to zero volts
while measuring GS. A high gain amplifier, A2, could amplify small changes in GS without
saturating the voltage produced by the releasing buffer itself. A National Instruments
PCI6071E, 12 bit A/D acquisition card (Austin, TX) was used to convert the analog
signal to a 12 bit digital signal.
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Figure 4.1 Circuit diagram for the conductivity sensor.
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4.2 Pressure Drop in a Microchannel with Blood Flow
The volume flow of blood (Q) in an enclosed microchannel can be calculated from a
modified version of Poiseuille flow using Equation 3.A2:

·

·

(4.2)

4

The hydraulic diameter of the microchannel (d) is given as

⁄ 2

,

where A is the channel cross-sectional area and ht and w represent the channel height
and width, respectively,
below) and

with

/

(4.3)

accounts for the viscosity-dependent hematocrit level of whole blood

determined from Equation 3.A4;

·
where

is the pressure drop (see

is calculated from;

1
The term

⁄

is the solution viscosity,

(4.4)

is the yield stress and is related to the blood hematocrit level (H) using;

0.1 · 0.625

(4.5)

From Equation 4.2, the pressure drop (∆ ) in a channel of length L can be calculated
from;

∆

(4.6)

4.3 Modeling Cell Capture Data as a Function of the Cell Translational Velocity (U)
To explain the experimental data in terms of capture efficiency versus the linear flow
rate, the data for the 35 µm wide sinusoidally-shaped channels was modeled by
adopting the 2-state model developed by Chang and Hammer, with the assumption that
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transport was dominated by convection (i.e., Pe >> 1, where Pe is the Peclet number
and represents the ratio of convective to diffusive mass transport).1 In this model, the
rate of capture of cells at a surface containing immobilized recognition elements
depends on the encounter rate and the reaction time. The rate of capture per
ligand/receptor pair (kf, s-1) can be calculated with Equation 3.A7;
(4.7)
where ko is the encounter rate and describes the rate of transport of cells to the wall
where the antibodies are immobilized and P is the probability of a reaction occurring
between the cell ligand (i.e., EpCAM) and surface receptor. For Pe >> 1, as in the
current experiments, kf is primarily reaction limited and is calculated using Equation 4.8;
(4.8)
where D is the cell diffusion coefficient and Nu is the Nusselt number, which describes
the flux of antigens to immobilized antibodies and can be approximated from 2

⁄ for

Pe >> 1. P is estimated from Equation 4.9;

Λ

where

1

Λ

is the dimensionless Damköhler number (

(4.9)

⁄ ; kin = intrinsic EpCAM:anti-

EpCAM reaction rate; a is the encounter radius) and Λ is the dimensionless encounter
time and is calculated from /

/

, where

8 / 3

. A plot of ko, P, and kf

versus the cell slip velocity, where the slip velocity is ~0.47U, are depicted in Figure 4.2.
The experimental data (% of input cells bound to the channel wall) can be used to
calculate the rate of adsorption, kads, from;

ln 1

%
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(4.10)

where L is the length of the capture channel and U is the translational velocity of the
cells within the fluidic channel. Finally, kads is related to kf through the relationship;
(4.11)
where

is the cell surface antigen density and

encounter area (2

). Therefore, a plot of

is the number of antibodies in the

versus

, which is obtained from the

experimental data, can be fit to Equation 4.8 with one adjustable parameter, kin, that is
used for the estimation of P.

2.0
1.8
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-9

P, ko (x10 ), kf (x10 )

1.6
1.4
1.2
1.0
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0.6
0.4
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0.0
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0.2

0.3

0.4

0.5

-1

Cell Slip Velocity (cm s )

Figure 4.2 Plot of P (black rectangles), ko (red circles) and kf (blue triangles) as a
function of the input cell slip velocity into a fluidic channel of dimensions 35 µm x 150
µm.
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Figure 4.3 Brightfield and fluorescence micrographs showing monoclonal antibody
captured CTCs in a PMMA microchannel. (A) Brightfield micrographs taken at 40×
magnification and (B) the corresponding fluorescence micrographs verifying the
captured cell is the fluorescently labeled CTC. The inset shown in Panel (A) is a
fluorescently-stained MCF-7 cell in a PMMA channel that was not decorated with antiEpCAM antibodies indicating the spherical shape of these cells.

4.4 Adhesion Strength of EpCAM:Anti-EpCAM Antibody Complex on a Surface
The adhesion force (

) between the cell and the antibody-decorated surface can be

determined from the bond strength between a single antigen:antibody complex ( ), the
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cell contact area with the PMMA surface (

) and the number of receptors poised on

the PMMA surface within the contact area of the cell (

) from:

(4.12)
If the cell is assumed to be a non-deformable object upon adhesion to the capture
surface, the contact area can be calculated using Equation 4.13;2

sin

(4.13)

where r is the cell radius and h and h' represent the characteristic cell separation
distances from the surface upon binding. Using h and h' as 100 Å and 400 Å,
respectively,3 the calculated contact area was determined to be 16.6 µm2 for the MCF-7
cells. If the cell is assumed to flatten and elongate after contact, as observed
experimentally (see Figure 4.3), the resulting contact area Ac is 456 µm2.4
The single EpCAM:anti-EpCAM antibody adhesion force was estimated using the
formalism by Bell,5 who developed the following expression for deriving the critical force
required to break a single bond (Equation 4.14);
(4.14)

where k is Boltzman’s constant, T is the absolute temperature, ro is the separation
distance between receptors at the minimum breaking force and

(K =

EpCAM:anti-EpCAM equilibrium constant). Using values from Table 3.1 and T = 298K,
a value of 6.7 x 10-6 dynes was calculated for
Dembo’s binding affinity model.4,6,7
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. The same result was found using

Table 4.1 Literature values for the complex between EpCAM and its monoclonal
antibody.
Parameter
Description
Value
Reference
Encounter radius
Forward rate constant for EpCAM - anti-

5 nm

1

0.99 x 105 s-1

8

12 µm

9

0.4

10

EpCAM binding
MCF-7 average cell radius
Blood hematocrit level
Cell selection bed length

35 mm

Microchannel hydraulic number

56 µm

11

MCF-7 cell diffusion coefficient

10-10 cm2 s-1

12

4.8 cP

10

282 µm-2

13

5.1 x 105

13

3.3 x 108 M-1

8

0.5 nm

1

2.3 x 1011 cm-2

14

Viscosity of blood (H = 0.4)
Cell

surface

density

of

EpCAM

-

calculated from the average surface
area of MCF-7 cells and the expression
level of EpCAM
Expression level of EpCAM in MCF-7
cells
EpCAM:anti-EpCAM

equilibrium

constant
Separation distance between receptors
at min. breaking force
NL

Substratum anti-EpCAM density on UVmodified PMMA
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Chapter 5 Highly Specific Selection, Isolation, and Enumeration of Escherichia
coli from Various Water Sources
5.1 Introduction
Escherichia coli (E. coli) are potentially enterohemorrhagic bacteria living in the
lower intestines of many mammals, and are typically known as gut flora. Their primary
function, when located in the intestines, is assisting in waste processing, vitamin K
production and food absorption. There are several hundred strains of E. coli; strains like
E. coli O157:H7 produce powerful “shiga-like” toxins (stx1, stx2) responsible for severe
illnesses including but not limited to bloody diarrhea, colitis, or even death in animals
and humans.1 E. coli O157:H7 also harbors a 43 kb pathogenicity island, termed the
locus of enterocyte effacement, which contains virulent attributes required for forming
lesions on hosts. Hemolytic-uremic syndrome (HUS) and seizures are presented in
infantile cases resulting from exposure of these pathogens to children.2 Physically, E.
coli is a rod-shaped bacterial cell with a length of 2 µm and a width of approximately 0.8
µm. In many cases, E. coli infiltrate various fresh water bodies by being carried via
runoff to tributaries and/or aquifers.3 These virulent bacteria are typically transmitted via
the fecal-oral pathway by ingesting contaminated water or food-stuffs.4
The food industry is particularly concerned with cross-contamination due to the
proximity of many domestic farm animals to various vegetative food crops in rural areas.
The turn-around time for laboratory tests often exceeds 2 wk.5 Thus, it has become
increasingly necessary to screen for these bacteria earlier in the food production cycle
in order to reduce the numerous potential health-related issues associated with
widespread outbreaks. To decrease the impact, implementation of testing at the earliest
possible point of intervention is required. Minimization of the scope of the impact from
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such contaminations is inextricably linked to developing portable, sensitive, isolation
and enumeration technologies that can be effectively applied by novice end-users.
A common strategy employed for determining the presence of E. coli is the ISO
9308-1 method in which water samples are membrane filtrated followed by the growth
of the isolated cells using lactose 2,3,5-triphenyltetrazoliumchloride (TTC) agar with
Tergitol 7.6 Coliforms reduce TTC producing a yellow-orange color indicative of rodshaped bacteria that ferment lactose to produce gas and acid within 48 h at 35°C.7
However, the major difficulties associated with this methodology are the time required to
produce readable results, and the ability for a broad cross-section of users to correctly
interpret the results. In addition, other organisms present in the water can elicit a
positive response (false positive for E. coli) and some E. coli strains do not ferment
lactose (false negatives).8 A recent comparison of different growth media for culturing E.
coli and various coliforms was presented.9 The results of the comparison study
indicated that m-ColiBlu24 and Colilert 18 chromogenic media provided faster and more
reliable results compared to the ISO standard media, but still required 22 h and 18 h,
respectively, to obtain reliable results compared to 72 h for the ISO 9308-1 method.
A recent report highlighted the ability of a molecular biological assay, BAX, to detect
and enumerate the presence of E. coli O157:H7 bacteria.10 In this assay, the
capabilities of real time polymerase chain reaction (RT-PCR) are used to specifically
test for strain-specific species using molecular markers unique to the strain. The authors
reported the ability to detect 10 CFUs in a processing time of 8 h, where CFU is defined
as “colony forming unit,” which is the number of viable bacteria. However, the process
required pre-concentration of samples containing low abundances of E. coli by filtering
the water sample using 0.45 µm cellulose ester filters followed by elution of the retained
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material. Then, the eluted volume was subjected to immunomagnetic selection using
anti-E. coli O157:H7 antibodies coated onto magnetic beads. Unfortunately, these
multiple processing steps made implementation of this assay for field deployment
prohibitive due to the extensive hardware requirements and the required operator
expertise. Though these virulent bacteria, impose imminent danger upon consumption
there exists no U.S. Food and Drug Administration mandate on maximum levels in any
food source.11 The total bacterial level at which action is taken by the FDA is currently
set at 104 CFU g-1 of sample (see Table 5.1).
Recreational waters including fisheries, boating, and swimming areas as well as
drinking water supplies have in recent years become breeding grounds for potentially
virulent bacteria.1 The US EPA allowable levels of E. coli are shown in Table 5.1.
Specifically, elevated levels of pathogenic bacteria such as E. coli O157:H7 can be
correlated to the increased occurrence of most water-related sicknesses, deaths, and/or
the development of harmful algal bloom formations.12 These waterborne pathogens are
assessed by first filtering large (100 mL) aliquots of water using porous membranebased filter paper that can also support the subsequent adherent cell culturing and
microscopic inspection of the bacteria such that a determination can be made as to
viability and toxicity. Upon harvesting and culturing the bacteria, morphological
examinations as well as pathogen specific immunoaffinity is often used.
There are a variety of emerging technologies for isolating cells from heterogeneous
samples with selection based on immunoaffinity or distinct reporter molecules that are
unique to the targets. The most promising developments include fluorescence assisted
cell sorters,1 flow through filtrations,13,14 enzyme linked immunosorbent assays
(ELISA),15,16 and immunomagnetic cell sorting.17-19 The commonality between these
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methods is the extensive use of prefiltration and arduous culturing protocols needed to
produce detectable levels of the bacteria. The most rapid of these assays can take up to
8 h. In addition, the required equipment and sample preparation phases of these assays
make them difficult to implement for wide-scale usage, especially in field-deployable
applications.

Table 5.1 Source and acceptable levels of E. coli
Source
Acceptable E. coli level, CFU/100 mL
20
Drinking
0
Wastewater20
20
Lake/River20
200(A) 1000(C)*
Meat/Produce21
104**
*(A)=Advisory **(C)=Closure. **Represents CFU g-1 which is the FDA action level.

In order to successfully analyze rare bacterial strains in complex samples, new
approaches are required. The ideal system would provide high specificity for selection
of the species/strain/source specific bacteria directly from waters or other complex
sample matrices from a variety of sources and also enumerate the number of colony
forming units (CFU) over a large dynamic range. The system should be simple to
operate and packaged into a compact unit that will permit field deployment. The
following characteristics should be associated with the device; (i) high throughput
sampling of mL volumes in <10 min of processing time concentrating the bacterial cells
to nL volumes; (ii) functionally compatible with immobilization strategies used to fix
capture elements to the capture bed; and (iii) amenable to small sensors with high
sampling efficiency for automated cell counting strategies. In any case, the volume
sampled is typically dictated by the frequency of the events to be assessed.

For

bacteria the US EPA recommends aqueous sample sizes of 100 mL20 and the US FDA
recommends solid samples sizes of 25 g.4
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Traditional microfluidic device architectures are encumbered by inherently low
throughput; however, when parallelization of features is employed, as in the design
delineated herein, it is possible to exhaustively interrogate large samples for rare
biological cells in short periods of time (see Fig. 5.1). In this manuscript, we present
preliminary results on the use of a novel technology directed toward the unambiguous
identification of microbial water supply contaminates using microfluidic devices that
enable selective cell isolation and subsequent enumeration using an integrated
conductivity sensor.

0.5 cm

Figure 5.1 AutoCAD 2008 rendering of a microfluidic device that can provide high
throughput miscro-sampling (HTMSU). The device used a series of microchannels that
were decorated with antibodies specific for the target cell. The antibodies were
immobilized beneath the gray shaded region, which consisted of 37 straight
microchannels that were uniformly 3 cm long and 30 µm wide. The entire device was
150 µm deep. The output end contained a conductivity sensor that consisted of a pair of
Pt wires placed orthogonal to the fluid flow path.

5.2 Materials and Methods
5.2.1 High-Throughput Microsampling Unit Fabrication. The substrate selected for
the high throughput micro-sampling unit (HTMSU) was poly(methyl methacrylate),
PMMA, due to its high fidelity for forming structures with high-aspect ratios via microreplication, minimal non-specific adsorption of E. coli cells to its surface and its ability to
generate functional surface-scaffolds through UV irradiation for the attachment of a
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variety of biological moieties.22 A molding tool was made via high precison micromilling
and the molding tool used to emboss microstructures into PMMA. Embossed PMMA
substrates and PMMA cover slips were cleaned with reagent grade isopropyl alcohol
(Sigma-Aldrich,

St.

Louis,

MO),

rinsed

with

nanopure

H2O

(Model

D8991,

BarnStead/Thermolyne, Dubuque, IA), sonicated with a model 8890 sonicator (Cole
Parmer, Vernon Hills, IL) for 15 min, rinsed with IPA again, and air dried. Then,
ultraviolet (UV) modification of the PMMA substrates and cover slips was performed
through an aluminum mask to facilitate the formation of carboxylic functional groups on
the PMMA surface for antibody immobilization. Both substrates and cover slips were
irradiated at 254 nm with 15 mW cm-2 for 10 min from the UV source (500W DUV;
Model UXM-501 MA; Ushio America, Cypress, CA). After UV modification, the glass
transition temperature (Tg) of the substrate was changed from 106 °C to 101°C.23 The
microdevice and cover slips were aligned and clamped between two glass plates and
fixed using clips (ACCO Brands, Inc., Lincolnshire, IL). The UV modified areas of the
device and cover slips were mated using alignment marks. The clamped unit was then
inserted into a programmable oven (Varian 3400, Palo Alto, CA) and the temperature
raised from 50°C to 101°C at a rate of 20°C/min with the final temperature held for 15
min. The total annealing time for each HTMSU was 17.6 min. A 15 cm long (inlet) and a
2 cm long (outlet), 237µm O.D. and 100 µm I.D. polyimide coated fused silica capillary
(Polymicro Technologies, Ave Phoenix, AZ) was epoxied between the substrate and
cover slip on the inlet and outlet sides of the HTMSU, respectively. An AutoCAD
rendering of the device is shown in Figure 5.1.
5.2.2 Antibody Immobilization. The HTMSUs were loaded with 4 mg mL-1 of 1-ethyl-3[3-dimethylaminopropyl] carbodiimide hydrochloride (EDC) and 6 mg mL-1 of N127

hydroxysuccinimide (NHS) in 150 mM 2-(4-morpholino)-ethane sulfonic acid (MES)
(Sigma-Aldrich, St. Louis, MO) at pH 6 for 1 h at room temperature to obtain the
succinimidyl ester intermediate of the carboxylated surface. The EDC/NHS solution was
removed by rinsing the fluidic network with nanopure H2O. Then, an aliquot of 1.0 mg
mL-1 of affinity purified polyclonal anti-E. coli O157:H7 antibody (K-log, Inc.,
Gaithersburg, MD) solution in 150 mM PBS (pH=7.4) (Sigma-Aldrich, St. Louis, MO)
was introduced into the HTMSU and allowed to react for 4 h.
5.2.3 Cell Suspension. E. coli O157:H7 cells were purchased from K-log, Inc.,
Gaithersburg, MD. The E. coli cells were stained with FITC using a lipophilic membrane
linker (PKH67, Sigma-Aldrich, St. Louis, MO). The cell density of the original E. coli
O157:H7 sample was 3 x 109 cells mL-1. Serial dilutions were performed to obtain the
desired cell density for each experiment.
5.2.4 Cell Capture Protocol. The HTMSUs were fixed onto the programmable
motorized stage of an Axiovert 200M (Carl Zeiss, Thornwood, NY) microscope and
videos were captured during each experiment at 30 frames per second (fps) using a
monochrome CCD camera (JAI CV252, San Jose, CA). A Xe arc lamp was used to
excite the fluorescent dyes incorporated into the cell membrane. A syringe pump was
used in an infuse mode to inject cell suspensions and buffers into the HTMSU. The
HTMSU was interfaced to a syringe pump (Model PHD2000, Harvard Apparatus,
Holliston, MA) using a syringe (Becton, Dickinson, and Company, Franklin Lakes, NJ)

and luer-to-CE adapter (InnovaQuartz, Phoenix, AZ). Pre-capture rinses were
performed with 0.2 mL of 150 mM PBS at 20 µL/min flow rates (270 mm s-1) to maintain
isotonic conditions. Then, 0.1 mL of a 10 cells µL-1 cell suspension was introduced at
2.0 mm s-1 linear velocity. Next, a post capture rinse was performed with 0.2 mL of 150
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mM PBS at 100 mm s-1 to remove non-specifically adsorbed cells on the HTMSU
surface. Finally, the numbers of cells captured by the antibody immobilized
microchannels were counted using brightfield and fluorescence microscopy for
confirmation of cell capture to the channel walls. Each experiment was performed in
triplicate for each linear velocity studied.
5.3 Results and Discussion
Microdevices with 30 µm wide channels that were 150 µm deep and 3 cm long were
used to assess the capture efficiency of the antibody-immobilized microfluidic device for
cylindrically-shaped E. coli cells (0.8 µm dia. × 2.0 µm long) from 10 µL suspensions
with densities of 100 E. coli cells µL-1. In order to determine if the antibody was
covalently tethered to the microchannel walls, fluorescently labeled antibodies were
used. In Figure 5.2, the fluorescence intensity from a microchannel with no labeled
secondary antibody, a microchannel loaded with 500 µg mL-1 anti-E. coli O157:H7
secondary antibody (K-log, Inc., Gaithersburg, MD), and a rinsed microchannel with
secondary antibody are shown. From these images, it was found that a buffer rinse
following antibody immobilization resulted in an increase in the average fluorescence
above background, strongly indicating the presence of tethered antibodies.
Experiments were next conducted in which E. coli strain K12 was used as a
negative control. Due to genomic differences, strain K12 lacks the capacity to express
the antigen targeted by the anti-E. coli O157:H7 antibody. As expected no E. coli K12
cells were isolated using this microfluidic device with O157:H7 antibodies (see Figure
5.3). In addition, the lack of K12 cells adsorbed to the channel wall provided evidence of
a lack of non-specific adsorption of these cells to the channel wall.
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Figure 5.2 Fluorescence image of a 20 µm wide microchannel decorated with surfaceimmobilized antibodies that were covalently labeled with a fluorophore. The control
trace, illustrated by a black dotted line, shows the PMMA microchannel in the absence
of the fluorescently-labeled antibody. The solid blue line represents the fully loaded
channel after it was infused with a solution containing 500 µg mL-1 of FITC labeled antiE. coli antibody in the presence of EDC/NHS. The red dashed trace shows an increase
in the fluorescence intensity corresponding to the immobilized antibody immobilized.
The two solid black lines represent the average fluorescence intensity before and after
the immobilization process.

Finally, the target O157:H7 cells were processed through the antibody immobilized
HTMSU.

Fluorescently-labeled

O157:H7

cells

were

selectively

isolated

from

suspensions at a 2.0 mm s-1 linear velocity. After processing 10 µL of the sample, the
captured cells were enumerated via fluorescence microscopy. The capture efficiencies
in three successive experiments was found to be 5.3%, 6.1%, and 8.7%. The low
capture efficiency can be attributed to the relatively wide linear microchannels used
here with respect to the width of these cells. The diameter of the E. coli cells was 0.8
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µm and the channel width used was >20× that of the targets. We have previously
shown, that by designing the capture microchannel width to dimensions similar to that of
the target cells can increase the capture efficiency by as much as 10-fold.24

A

B

Figure 5.3 A) The micrograph shows 9 captured E. coli O157:H7 cells indicated by
arrows. The cells were isolated from a suspension with cell density of 100 E. coli
cells/µL using an antibody immobilized microdevice. B) The panel shows that no E. coli
strain K12 cells were isolated when a suspension of equal density of the innocuous
strain was analyzed.

In addition, previous experiments indicated that linear microchannels are not ideal
for capturing cells, because the cell trajectories are parallel to the microchannel walls
with cell focusing resulting from hydrodynamic effects resulting in low numbers of “cellwall”

interactions

producing

fewer

capture

events.

Incorporating

curvilinear

microchannels can further increase the recovery due in large part to the inertia of the
cells, imparted by centripetal forces resulting from traversing the curved region of the
microchannels.
5.4 Conclusion
A new approach toward the isolation of low abundant E. coli cells has been
presented in which the number of cells in mL-scaled samples can be ascertained
without the need for long incubation periods and bacterial culturing procedures that
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result in analysis times exceeding 48 hrs. The E. coli O157:H7 cells were specifically
indentified and immobilized using immunoaffinity. Further investigations are warranted
for the capture and enumeration of E. coli cells to increase the capture efficiency and
provide the ability to sample larger volumes in minimal processing times. Micromilling
has proven effective in producing devices with multilevel structures for circulating tumor
cell isolation and enumeration,24 yet as evidenced by the low capture efficiencies
presented here, this fabrication technique is not suitable for producing architecture
appropriate for E. coli isolation. The maximum capture efficiencies in the devices
presented herein are limited due to the minimum channel widths (~20 µm) that
micromilling is commensurate with producing. Future efforts should focus on
engineering microdevice designs specifically for E. coli. To improve upon capture
efficiency, it would be suggested to produce devices with a maximum width of 2 µm and
depth of 40 µm corresponding to a minimum aspect ratio of 20, an aspect ratio that can
be used to replicate parts in polymers using embossing. Using these parameters, x-ray
lithography is ideally suited for production of moulding tools containing these narrow
and deep channels required for effective E. coli isolation. In addition, to increase
throughput thereby reducing analysis time the number of parallel processing channels
should be increased. For example, the use of 2,000 parallel channels would allow for a
volume flow rate of 19.2 µL min-1 maintaining a linear velocity of 2 mm s-1 to maximize
capture efficiency through the selection channels of the device and producing a 1 mL
processing time of 52 min. If the aspect ratio of this device were doubled while
maintaining the channel width, the throughput would also double thereby reducing the
processing time to 26 min per analysis.
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Chapter 6 Future Work: Continued Biosensor Research at United States Naval
Research Laboratory, Washington D.C.
6.1 Introduction
Explosives pose major security and environmental risk in this era of immanent
domestic terroristic activity.1 In addition, the existence of explosive nitroaromatics such
as TNT at various military sites and munitions testing grounds throughout the United
States require environmental monitoring of residual unexploded ordnance as well as the
degradation products of detonated nitroaromatics in groundwater and soil.2 Finally,
forensic investigations, as they pertain to domestic terroristic activities, also dictate that
field deployable assessment tools be readily available for untrained field technicians to
employ in order to rapidly determine the safety of emergency medical personnel and
other first responders.2
Off-site chemical analysis has been performed using traditional instrumentation
including high performance liquid chromatography,3 gas chromatography coupled to
mass spectrometers,4 surface enhanced Raman spectroscopy,5 cyclic voltammetry,6
and energy dispersive x-ray diffraction7 in the analysis of various explosives. These
methods have successfully delivered high sensitivity and selectivity for the analytes yet
these methods offer limited portability which detracts from their potential for being field
deployable. Size notwithstanding, these instruments further require the significant
expertise to employ. Microarray biosensors that involve the displacement of analogues
have been employed in the field with promising results, but the traditional mass
transport limitations in conventional microarrays and microfluidics inhibit the ability to
reliably detect sub-pg/mL amounts of the analytes from bulk solution reliably.1 To date,
the most prolific field deployable detection system has been the extensively trained
canine,

but

unfortunately,

these

animals
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are

expensive,

require

continuous

maintenance, and are subject to fatigue. Further, the canine’s strong sense of smell is
rendered ineffective when the analyte or target is submerged in groundwater.2
The nature of explosives and concern for the safety of the analyst or sample
collector suggest the need for sensing these dangerous and potentially toxic (≥ 2
ng/mL) environmental contaminants remotely.8 This is especially important in the cases
where the analytes consist of plumes of unexploded ordnance that has the potential for
accidental detonation. Therefore, sensors for explosive nitroaromatic compounds that
offer new approaches to the rapid, highly sensitive and selective remote detection of
trace levels of various explosives are warranted. Proposed herein is a novel approach
with application of high aspect ratio microstructures designed to meet three primary
requirements: 1) reduction of false positive and false negative responses in complex
matrices, 2) rapid analysis time, and 3) capable of sampling large volumes.
6.2 Materials and Methods
6.2.1 Apparatus and Protocol. Three peristaltic pumps (Lee Company, Westbrook,
CT) connected to high aspect ratio microfluidics via fused silica capillaries will be
employed to hydrodynamically infuse/effuse samples, regenerate fluorescent surface,
and wash the antibody coated device. The custom pumps are designed expressly to be
incorporated into field deployable portable devices employing microfluidics as indicated
by the design incorporating a small rugged outer casing, low power consumption,
capability of delivering as low as 0.1 μL per step, and five hundred total steps for all
chamber volumes. The pumps have 0.25 ms response times and can be configured
with chambers that range from 10 μL – 1.25 mL. The pumps also allow solution pass
through, when the pumps metering piston is in the full open position, to vent or send
processed components to waste vessels. Each pump has a vent system designated V1,
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V2, and V3 that corresponds to each pumps designation P1 through P3. Two of these
pumps (P1 and P2) will be connected to the inlet side of a Y oriented interface designed
to accommodate two feeding capillaries with P1 dedicated to delivering the fluorescently
labeled analogues, surface regeneration, that adsorb to the antibody immobilized
surfaces aiding the establishment of a baseline fluorescence signal from which
displaced fluorescence corresponds to bound target.1 P2 on the inlet side of the device
will be used to sample the ambient environment of the system on command in
conjunction with P3 which is connected to the effluent side of the microsampling unit.
With P2 in the open position P3 will be actuated instituting uptake of the sample. In
order to interface the pumps to the high throughput microsampling unit (HTMSU), a
PEEK-to-capillary (Hamilton, Reno, NV) adapter kit will be fitted with a luer-to-capillary
adapter (InnovaQuartz, Phoenix, AZ). The pumping system will be designed to generate
the appropriate volume flow rate to quantitate TNT over a broad linear dynamic range of
relevant (subpicomolar – nanomolar)) TNT plume concentrations. The capture efficiency
on an antigen flowing over a bed of immobilized antibodies has been shown to be
dependent of the flow rate and the length of column used.9-11 Also critical is the size of
the capture bed. In earlier experiments, the amount of antibody bound to a fixed surface
increased with increases in capture bed size. Also observed in these experiments was a
decrease in the %RSD of measurements in which more analyte was obtained and
quantitated implying improvement in measurement precision can be achieved when
isolating more analyte.9,10
The high throughput microsampling unit (HTMSU) will be fixed to the stage of an
inverted microscope initially, allowing for monitoring the release and/or adsorption of the
chromophores to the HTMSU using fluorescence imaging via a high sensitivity CCD
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with excitation via Xe arc lamp and dye-specific filter sets appropriate for the chosen
chromophores. Ultimately, linear dynamic range and limits of detection will be
determined using laser induced fluorescence measurements, reported literature values
of existing displacement based sensors are 3 orders of magnitude and 1.0 pg/mL,
respectively.
In order to reduce the potential for false negatives and positives a multifaceted
detection system would be incorporated. First, the analytes would be selected using a
displacement immunoassay where antibodies directed toward the nitroaromatics would
be covalently tethered to the surface of the microfluidic platforms forming stable capture
beds used to selectively isolate the targets while confining these analytes to low
nanoliter volumes effectively preconcentrating the analyte. The displacement process is
shown in equations below in which the antibody (Ab) is bound to the fluorescently
labeled antigen (Ag*). The binding affinity of the target has a binding affinity that is
typically two orders of magnitude greater than that of the analogue thus in the presence
of the target the antigen (Ag) displaces the analogue producing the means of signal
transduction.
Ab
AbAg

AbAg

Ag
Ag

AbAg

Ag

A CCD would be employed in the displacement based assay to monitor the loss of
fluorescence over time. Correlating the displaced fluorescently labeled analogues direct
proportionality to the bound analyte thereby allowing for calibration based quantitation
with broad linear dynamic range is possible in the displacement assay owing to binding
more of the analyte at lower concentrations. In the displacement format, two forms of
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quantification will be employed thereby providing both sensitivity and selectivity whereby
the elimination of false readings can be reduced or eliminated.
Incorporation of high throughput microfluidic systems as the analysis platform offers
high surface area to volume ratios which in turn allows for processing large sample
sizes in short time periods. In conventional microfluidics sample injection volumes in the
picoliter range are typical allowing for only a small amount of analyte to be processed
resulting in lower overall signal to noise than could be realized were the sample size
increased to the milliliter range and exhaustively interrogated prior to sensing. This
mass sensitive approach to analyzing nitroaromatics would be analogous to “purge and
trap” techniques employed by US EPA methods that involve chromatographic analyses
of volatile organics. Using anti-TNT antibodies with high binding affinity to select and
isolate more target from larger sample sizes provides the potential of unparalleled
sensitivity especially when coupled to conductance based detection systems similar to
those reported to achieve attomolar sensitivities of proteins on microfluidic platforms.12
Ultimately, these analyses will take place submerged thus requiring a closed system
capable of being isolated from an aqueous environment. The HTMSUs are closed
systems that are not prone to leakage and when integrated are capable of withstanding
significant outside pressure.13,14
6.2.2 High Throughput Microsampling Unit. Microfabricated devices featuring high
aspect ratio microstructures offer unparalleled throughput within high surface area to
volume ratio conduits. This is particularly attractive when exhaustively interrogating
large samples with low analyte concentrations for the purpose of quantitation is desired.
The proposed microfluidic will incorporate multiple microfluidic channels to reduce the
pressure drop across the device while allowing for high volume throughput over short
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time periods. The advantage realized from this type of assay will be manifested in the
preconcentration of many analyte molecules from approximately 1 mL samples as
opposed to that of traditional microfluidics. For example, traditional microfluidics
typically offers picoliter sample volumes, which when considering a sample that has
nanomolar analyte concentrations reliable quantitation becomes increasingly prohibitive
due to each picoliter only containing only a miniscule 602 molecules. Increasing the
sampling efficiency allows for a dramatic increase in the number of analytes molecules
available to for transduction at the detector thereby easing the restrictions on applicable
detection strategies.
The proposed device will consist of a series parallel high-aspect ratio channels
sharing common input/output ports. The devices will be replicated from a mold masters
using hot embossing as described in detail elsewhere.15 Briefly, the substrate selected
for the HTMSU is PMMA due to its high fidelity of forming structures with high-aspect
ratios via micro-replication, minimal non-specific adsorption of biological components to
its surface and its ability to generate functional surface-scaffolds through UV irradiation
for the attachment of a variety of biological moieties.13,16 Initially, microstructures will be
milled onto the surface of a brass plate with a high-precision micromilling machine
(KERN MMP 2522, KERN Micro- und Feinwerktechnik GmbH & Co.KG; Germany)
following our previously published procedures.15
Using this technique three identical HTMSUs can be patterned onto the brass
master enabling production of the polymeric units in triplicate during each hot
embossing step. In order to accommodate the Pt electrodes used for the conductivity
sensor and the inlet/outlet capillaries, the HTMSU was designed with multilevel
features.15 As an example of flexibility, in our previous work, the depth of features on an
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analogous microfluidic’s detection zone was tapered to 80 µm from the 150 µm used in
the cell selection beds and throughout the inlet region. The detection channel width was
tapered from 100 µm to 50 µm over a 2.5 mm region beginning at the converged outlet
and terminating 2.5 mm from the conductivity electrodes scaled for specific detection of
CTCs. In the cell selection bed, channel widths (35 μm) that closely matched the
average target cell diameter were used to increase the probability of cell-immobilized
antibody encounters. In the proposed selection of TNT, initial experiments will be
performed in 25 – 75 μm wide channels that are 150 μm deep to evaluate the effect of
aspect ratio on the isolation and quantitation of TNT. To reduce the pressure drops
when the device was operated at high volumetric flow rates, the HTMSU was designed
with deep (150 μm), high-aspect ratio channels. For quantitation a conductivity detector
was used. The sensitivity is governed by the cell constant (K) which is defined as L/A
where L is the separation distance between the electrodes and A is the total surface
area of the electrodes. The total conductance (G) is defined as:
G=

(λ+ +λ- )C
1000K

where C is concentration of the analyte, λ+ and λ- are limiting ionic conductance for the
cations and anions, respectively. By establishing a baseline conductance for the run
buffer the magnitude of perturbations of the baseline conductance in a given assay can
be directly related to analyte concentration in the effluent.
6.2.3 Surface Modification. Regio-specific ultraviolet (UV) modification of the PMMA
substrate and cover plate is performed through an aluminum photomask to facilitate the
formation of the carboxylated scaffold for directed antibody tethering exclusively within
the cell selection beds of the HTMSU. Before final assembly via thermal fusion bonding,
the PMMA cover plate and substrate will be irradiated at 254 nm with 15 mW cm-2
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fluence for 10 min using a UV exposure station (ABM, Inc., San Jose, CA). Additionally,
into the inlet/outlet ports of the device were inserted 237 μm OD and 150 μm ID
polyimide-coated fused silica capillaries and the Pt electrodes fabricated with the
required gap. After thermally annealing the cover plate to the substrate, a thin film of
epoxy resin will be applied to the capillary-device interfaces to prevent leaks.
Following UV modification of PMMA, the physicochemical properties of the surface
are effectively altered resulting in a moderate reduction of the glass transition
temperature (Tg) at the cover plate-substrate interface. The resulting Tg allowed for
efficient thermal fusion bonding at 101°C rather than the 106°C Tg of pristine PMMA,12,17
which reduces potential thermal deformation of the high-aspect ratio microfeatures.
Thermal fusion bonding will be performed using a temperature programmable ovensuc
as that contained in gas chromatograph (Varian 3400, Palo Alto, CA) using the PMMA
cover plate and the open-faced, hot embossed PMMA substrate. The substrate and
cover plate will be aligned and clamped together between two borosilicate glass plates
and the assembly placed into the temperature programmable oven of the GC, where the
temperature will

be increased from 50°C to 101°C at a rate of 20°C/min. The

temperature was held at 101°C for 15 min.
6.2.4 Antibody Immobilization. Covalent antibody immobilization will be performed
using a two step process. Initially, the UV-modified HTMSU device, following thermal
assembly, will be loaded with a solution containing 4.0 mg/mL of 1-ethyl-3-[3dimethylaminopropyl]

carbodiimide

hydrochloride

(EDC),

6.0

mg/mL

of

N-

hydroxysuccinimide (NHS) in 150 mM 2-(4-morpholino)-ethane sulfonic acid at pH = 6
(MES, Fisher Biotech, Fair Lawn, NJ) and buffered saline (Sigma-Aldrich, St. Louis,
MO) for 1.0 hr to form the succinimidyl ester intermediate. The EDC/NHS solution will
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then be hydrodynamically replaced with a 1.0 mg/mL anti-TNT antibody (Biological
Detection Systems, Pittsburg, PA) solution contained in 150 mM PBS at pH = 7.4
(Sigma-Aldrich, St Louis, MO) and allowed to react for 4 h after which the device will be
rinsed with a solution of PBS (pH = 7.4) to remove any non-specifically bound moieties
from the surface.
6.2.5 Integrated Conductivity Sensor. Conductivity electrodes will consist of Pt wires
(25 – 127 µm dia.) placed into guide channels of equal width and depth embossed
orthogonal to the fluidic output channel. The Pt wires will be inserted into these guide
channels prior to thermal assembly of the cover plate to the substrate. Once the wire is
positioned, the substrate/wire assembly will be placed between glass plates and
clamped together and finally, heated to a temperature slightly higher than the glass
transition temperature of PMMA, once embedded the wire spanned the entire depth of
the output channel. To break through the wire to form the electrode pair, a high
precision micromilling machine (KERN MMP 2522, KERN Micro- und Feinwerktechnik
GmbH & Co.KG; Germany) with a 50 μm bit was used. Following machining of the Pt
wire and UV activation, the cover plate will be aligned to the embossed substrate via
alignment marks and clamped together between two glass plates and subjected to
thermal fusion bonding.
Conductivity measurements will be conducted in the run buffer where the critical
components are compatibility with the analyte and fluidic system. The releasing buffer
will be carefully selected in large part for its relatively low conductivity (~50 µS/cm, pH
7.2) and the addition of trypsin to digest the antibodies facilitating the removal of the
bound TNT from the capture channel surface for conductometric quantitation.
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6.3 Expected Results and Significance
The current state of the art displacement based immunological measurements offers
at the optimum flow rate of 100 μL/min analysis times of 3 min using a single capillary
with 0.55 mm i.d. that was 20 cm long.9-11,18 These experiments were characterized by
less than ideal analyte recovery rates and deviations from linearity in quantitative
measurements on samples above 300 ng/mL. Linearity in the previous schemes was
limited to 2 to 3 orders of magnitude. Refining the isolation and release of the analytes
for secondary measurements the linear dynamic range may be extendable. Tuning the
microfluidics to capture the analytes more effectively and incorporating these features
on a single chip it is possible to increase the sensitivity and limit of detection of the
measurement systems while reducing the overall analysis time. For instance, if an
HTMSU were employed with 50 parallel channels with matching cross section to those
mentioned above the processing time for a 100 μL sample could be reduced 3 min to
0.06 min. Incorporating high aspect ratio microchannels offers high surface area to
volume ratios resulting in more exhaustive interrogation of samples leading to higher
capture efficiencies. It stands to reason that if one extracts more of the analyte from the
sample that the slope of the subsequent calibration curve would also increase thereby
affording higher sensitivity.
6.4 Dissertation Summary
After a brief overview of the recent literature on CTC isolation and enumeration in
microfluidic devices in Chapter 1, this dissertation initially focuses on the electrokinetic
manipulation of biological cells within polymeric microfluidic devices in an effort to
demonstrate the separation of mixed cellular populations. During my early work, I
demonstrated that through manipulation of simple parameters such as solution ionic
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strength, substrate surface chemistry, and the bulk composition of the substrate used
that the apparent mobilities of cells in mixed populations could be exploited to effectively
separate mixed populations of cells into its individual constituents. Also shown in my
early work was the use of Rayleigh scatter to both distinguish cells based on size and
as a means of direct quantitation. The basis for the enumeration and typing in the early
work was that the larger particles or cells in suspension scattered more light than the
smaller counterparts as indicated in Chapter 2. Though this work represented a
significant stride in the community this work had a few drawbacks, primarily related to
low throughput, incompatibility with densely populated samples, and enriched cells were
of relatively low purity.
In an effort to improve upon some of the initial drawbacks of my early work, in
Chapter 3 and 4, I expound on the development of a microfluidic device termed: high
throughput microsampling unit (HTMSU), which simplified cell analysis greatly. The
devices were micromanufactured with multilevel microstructures via a novel high
precision micromilling technique developed in-house. The microstructures possessed
aspect ratios greater than four and served to improve throughput by running identical
channels in parallel. Further, the devices improved the sample interrogation by
increasing the surface area to volume ratio by an order of magnitude, thereby exposing
more of the sample to the capture elements improving the overall effectiveness of the
protocol. Also within this device was a regiospecifically modified region which served to
selectively isolate cells from suspension through an immunoaffinity based interaction
between immobilized antibodies and membrane bound antigens expressed in the
periphery of the target cells. These devices were used to analyze whole blood samples
for low abundant target cells without the need for sample pretreatment.
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Finally, I transcended the confines of traditional disease related bioassays, and
extended the technology to environmental samples in an effort to improve the
turnaround time, sensitivity, and portability of traditional groundwater assessment. As a
model analyte E. coli was chosen due to its toxicity and its adverse impact on
recreational waters in the form of beach closings due to elevated levels. The analysis of
E. coli using HTMSUs continues to be a challenge due to many factors. The bacteria
were much smaller than that of the cancer cells used in the proof of concept discussed
in Chapter 3 and 4, hence capture efficiencies of no greater than 14% were obtained in
initial experiments. Also, the conductivity sensor had to be modified in order to discern
the smaller perturbations at the conductivity cell produced by the much smaller
bacterium as it traversed the detector. In addition using brightfield microscopy the E. coli
were difficult to distinguish when captured on microchannel walls even when
fluorescently labeled because of the size and the relatively small depth of field when
compared to the total channel depth.
6.5 Immediate Projections
With minor modifications to the devices such as narrowing the channel widths,
changing the immobilized antibodies, and optimizing the processing velocity this
technology will be widely applicable. Experimental optimization of the parameters will
have significant impact on extending the applicability in disease diagnostics and
prognostics. In the clinical setting, small relatively inexpensive devices with long shelf
lives are required, and the advent of aptamers provide a basis for increased thermal
stability with similar Kd values to antibodies directed towards the same target. Also,
efforts are underway to facilitate the integration of molecular profiling techniques to the
current devices that nondestructively isolate and enumerate the CTCs. By lysing the
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cells, capturing the DNA via solid phase reversible immobilization, and performing onchip continuous flow polymerase chain reaction (cf-PCR) we will someday circumvent
the current state of the art screening techniques such as colonoscopy, mammography,
and magnetic resonance imaging.19,20 Further, in the environmental regime,
investigation with these devices will yield assessment of environmental samples for low
abundant bacterial cells, phytoplankton, and the devices will ultimately be used to trap
and quantitate molecules as well as bacteria. Field deployability for environmental
analysis and device shelf life will be improved by incorporating aptamers, small
oligonucleotides that bind proteins with affinities that compare favorably with antibodies,
because they are thermally stable and possess long shelf life.
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